Skip to main content
eLife logoLink to eLife
. 2023 Mar 23;12:e83979. doi: 10.7554/eLife.83979

Nutrigenomic regulation of sensory plasticity

Hayeon Sung 1,, Anoumid Vaziri 1,2,, Daniel Wilinski 1, Riley KR Woerner 1, Peter L Freddolino 3,4, Monica Dus 1,2,5,
Editors: Dion K Dickman6, K VijayRaghavan7
PMCID: PMC10036121  PMID: 36951889

Abstract

Diet profoundly influences brain physiology, but how metabolic information is transmuted into neural activity and behavior changes remains elusive. Here, we show that the metabolic enzyme O-GlcNAc Transferase (OGT) moonlights on the chromatin of the D. melanogaster gustatory neurons to instruct changes in chromatin accessibility and transcription that underlie sensory adaptations to a high-sugar diet. OGT works synergistically with the Mitogen Activated Kinase/Extracellular signal Regulated Kinase (MAPK/ERK) rolled and its effector stripe (also known as EGR2 or Krox20) to integrate activity information. OGT also cooperates with the epigenetic silencer Polycomb Repressive Complex 2.1 (PRC2.1) to decrease chromatin accessibility and repress transcription in the high-sugar diet. This integration of nutritional and activity information changes the taste neurons’ responses to sugar and the flies’ ability to sense sweetness. Our findings reveal how nutrigenomic signaling generates neural activity and behavior in response to dietary changes in the sensory neurons.

Research organism: D. melanogaster

Introduction

The levels and types of dietary nutrients play an essential role in cellular processes such as growth, division, and differentiation by providing fuel and biomass. However, nutrients can also affect these aspects of cell physiology by influencing, and often orchestrating, gene expression programs (Vaziri and Dus, 2021; Dai et al., 2020). These effects are mediated through nutrient-sensitive modifications to DNA, RNA, and proteins, as well as changes to the activity, binding, and localization of enzymes and signaling factors (Huang et al., 2015; Katada et al., 2012). These nutrigenomic signaling pathways – nutrigenomics is the field that studies food–genes interactions – could explain how the food environment affects the risk of non-communicable diseases such as diabetes, cancer, and neurodegeneration. They also hold the potential to uncover new interventions and treatments for these debilitating diseases. While the effects of nutrients on gene expression are well established, relatively little is known about the molecular mechanisms at the food–gene interface. A significant challenge of the field has been to explain how global variations in the nutrient environment lead to changes in cell physiology and behavior, especially in neuroscience. To overcome these challenges, we have developed an experimental system where the contributions of nutrients to physiology can be studied mechanistically and in vivo (Vaziri and Dus, 2021). Here, we use this model to characterize how changes in metabolic signaling due to diet are integrated with cellular context to diet nutrient adaptations.

Taste sensation changes depending on diet composition. In animals, the levels of bitter, sweet, and salty foods influence how these taste stimuli are perceived, with a general inverse relationship between the amount of a particular food in the diet and the responses of the sensory system to it (May and Dus, 2021; Sarangi and Dus, 2021; Reed et al., 2020). For example, in humans and rodents, the dietary concentration of sugars affects sweetness intensity or the electrophysiological responses of the sensory nerves to sucrose (Wise et al., 2016; McCluskey et al., 2020; Sung et al., 2022; Sartor et al., 2011; May and Dus, 2021). A similar phenomenon occurs in flies, where diets supplemented with 15–30% sucrose, glucose, or fructose decrease the responses of the sensory neurons to sucrose and the transmission of the sweetness signal to higher brain areas (May et al., 2019; Vaziri et al., 2020; Wang et al., 2020; Ganguly et al., 2021; May et al., 2020). In rats and flies, the dulling of the sensory system to sugar occurs even without weight gain, suggesting that diet exposure is sufficient to drive sweet-taste plasticity (Sung et al., 2022; May et al., 2019). Our previous work in flies implicated metabolic signaling through the Hexosamine Biosynthesis Pathway (HBP) enzyme O-GlcNAc Transferase (OGT) in this phenomenon (May et al., 2019). Specifically, knockdown of OGT exclusively in the fly sweet-taste cells prevented the neural and behavioral decrease in sugar responses observed with a high-sugar diet (May et al., 2019). OGT uses the metabolic end-product of the HBP, UDP-GlcNAc, to post-translationally modify proteins and change their stability or activity (Hart, 2019). OGT activity is sensitive to all cellular levels of UDP-GlcNAc without substrate inhibition, but it is enhanced by high dietary sugar due to a higher flux through the HBP (Hanover et al., 2010; Bouché et al., 2004; Hawkins et al., 1997; Marshall et al., 2004; Wang et al., 1998; Olivier-Van Stichelen et al., 2017; May et al., 2019; Wilinski et al., 2019; Na et al., 2015). OGT is also a nucleocytoplasmic protein that interacts with many chromatin- and DNA-modifying complexes; as such, it is thought to function as a nutrigenomic sensor, bridging diet and genes (Olivier-Van Stichelen et al., 2017; Olivier-Van Stichelen and Hanover, 2015; Hart, 2019; Hardivillé and Hart, 2014). Despite global changes in HBP flux with high dietary sugar, the consequences of OGT activity differ among cell types. Understanding how this occurs would provide an opportunity to study how nutrigenomic signaling is integrated with cell-specific contexts, like activity, to generate unique adaptations. Here, we exploited the effects of OGT on Drosophila sensory neurons and the exquisite genetic tools of this organism to investigate this question. Our experiments reveal that nutrigenomic signaling synergizes metabolic state with ongoing cellular physiology to integrate cellular signals. In the sensory neurons, OGT decorates nutrient-sensitive loci also occupied by the epigenetic silencer PRC2.1 and the activity-dependent ERK effector Stripe (Sr). This cooperation leads to changes in chromatin accessibility and transcription that drive sensory plasticity, and the catalytic activity of OGT plays an instructional role in this process. Thus, our results uncover mechanistic insights into how nutrigenomic signaling translates nutritional information into dietary adaptations in the sensory neurons.

Results

The nutrient sensor OGT decorates the chromatin of sweet sensory cells

Since transcriptional changes have been implicated in sugar diet-induced taste plasticity (Vaziri et al., 2020; May et al., 2019; Wang et al., 2020) and OGT associated with chromatin-binding factors (Vella et al., 2013; Gao et al., 2018; Hart et al., 2011; Gambetta and Müller, 2015), we asked whether this metabolic enzyme moonlights on the chromatin of sweet-taste neurons. We used DNA adenosine methyltransferase Identification (Dam-ID or TaDA) to measure the association of OGT with DNA (Marshall et al., 2016; van Steensel and Henikoff, 2000) and Chromatin Accessibility profiling using Targeted DamID (CaTaDA) to assess chromatin accessibility (Sen et al., 2019). Transgenic UAS-LT3-Dam::OGT or UAS-LT3-Dam flies were crossed with Gustatory Receptor 5a GAL4 (Gr5a) flies (Chyb et al., 2003) to drive expression exclusively in the ~60 sweet-taste cells of the fly mouthpart, and Tubulin-GAL80ts to control the timing of transgene induction. Gr5a>LT3-Dam::OGT; tubulin-GAL80ts (green) and Gr5a>LT3-Dam; tubulin-GAL80ts (yellow) transgenic flies were kept at the permissive temperature and fed a control (CD, 5% sucrose) or sugar (SD, 30% sucrose) diet for 3 days (Figure 1A). Dam::OGT and Dam were then induced by heat shocking the animals at 28°C for 18 hr on day 4, as in our prior experimental design (Figure 1A; Vaziri et al., 2020). The normalized Dam::OGT replicates clustered together by diet (Figure 1—figure supplement 1A), and the chromatin accessibility profile of Dam at the Gr5a sweet-taste receptor gene promoter was high, while at the bitter Gustatory Receptor 66a (Gr66a) promoter – only expressed in adjacent cells – accessibility was low (Figure 1—figure supplement 1B), suggesting that these transgenes were targeted to the correct cells.

Figure 1. O-GlcNAc Transferase (OGT) decorates the chromatin of the sweet-taste cells.

(A) Design of Targeted Dam-ID for OGT occupancy (Dam::OGT) and Dam accessibility (CATaDa) experiments. Age-matched Gr5a;tubulin-GAL80ts>UAS-LT3-Dam::OGT and Gr5a;tubulin-GAL80ts>UAS-LT3-Dam flies were placed on a CD or SD for 3 days at 20–21°C and then switched to 28°C between days 3 and 4 to induce expression of the transgenes. (B) Annotation of OGT chromatin occupied regions (all peaks) using HOMER. (C) The proportion of observed Dam::OGT consensus peaks allocated to their respective chromatin domains normalized to the expected proportions across the whole genome. Heterochromatin: black, high in H3K27m; green, bound by HP-1, high in H3K9me2; blue, bound by Polycomb Group Proteins, high in H3K27m. Yellow and red euchromatin are high in H3K4me2 and H3K79m3; yellow is also enriched for H3K36me3. (D) The distribution in normalized reads (Transcript Per Million, TPM + 1) for genes occupied by OGT (green). Two-tailed t test, ****p<0.0001 (E) Overlap of log2(Dam::OGT/Dam) chromatin-binding peaks of CD (light green) and SD (dark green) (find_peaks, q < 0.01). (F) Average CATaDa signal on CD (light yellow) and SD (dark yellow) centered at OGT peaks. (G) iPAGE summary plots for OGT peaks on a CD (top left), SD (bottom left), and the difference of SD/CD (right). Text in blue represents neural GO terms, orange represents metabolic GO terms, and green represents regulatory GO terms.

Figure 1.

Figure 1—figure supplement 1. O-GlcNAc Transferase (OGT) resides on the chromatin of the Gr5a+ neurons.

Figure 1—figure supplement 1.

(A) Principal component analysis of normalized log2(OGT::Dam/Dam) flies on CD (light green) or SD (dark green). (B) CATaDa from control diet flies at the sweet gustatory receptor Gr5a and the bitter gustatory receptor Gr66a. (C) Average CATaDa signal on CD (light) and SD (dark) centered at OGT peaks for genes in the blue and yellow chromatin intervals.
Figure 1—figure supplement 2. Pathway enrichment analysis of O-GlcNAc Transferase (OGT) chromatin targets in the Gr5a+ neurons.

Figure 1—figure supplement 2.

iPAGE identification of pathways depleted (blue) or enriched (red) compared to background gene list from the OGT::Dam peaks on a control, sugar, and difference of sugar/control diet. The scale represents over-representation (red) or under-representation (blue) of genes within a specific bin for the corresponding GO term. Black outlined boxes represent q < 0.05.

Dam::OGT was associated with chromatin at introns (51%) and transcriptional start sites (TSSs) and promoters (30%) (Figure 1B, Supplementary file 1; all peaks); these patterns are similar to those observed in the only other study that measured OGT occupancy on the chromatin of mouse embryonic stem cells (Vella et al., 2013). In flies, chromatin has been classified into five types according to the histone modifications present and the proteins bound (Filion et al., 2010). In this chromatin characterization, there are three types of heterochromatin, developmentally regulated ‘black’ chromatin (high in Histone (H) 3 Lysine (K) methylation, H3K27m), Heterochromatin-protein 1 (HP1) associated ‘green’ chromatin (high in H3K9me2), and Polycomb group proteins-bound ‘blue’ chromatin, and two types of euchromatin (high in H3K4me2 and H3K79m3), the actively elongating H3K36me3 ‘yellow’ chromatin enriched in nucleic acid metabolism genes and the ‘red’ chromatin enriched in other cellular processes (Filion et al., 2010). Our analysis found that OGT was enriched in transcriptionally active yellow euchromatin (453 genes), consistent with its role in splicing, and at ‘blue’ Polycomb heterochromatin (415 genes), consistent with the known associations between Polycomb Group proteins and this metabolic enzyme (Gambetta et al., 2009; Hart, 2019; Figure 1C). As expected, the accessibility at yellow chromatin intervals was higher than that of blue chromatin regions (Figure 1—figure supplement 1C).

We next examined the differential binding of OGT between the two diets. Although the majority of intervals were shared between a CD and SD (Figure 1E, find_peaks False Discovery Rete (FDR) <0.01), a few hundred loci were uniquely associated with OGT in either the CD (36%) or SD (10%) only conditions. However, the chromatin accessibility at OGT-bound peaks decreased in the high-sugar diet condition (Figure 1F, both at blue and yellow regions, Figure 1—figure supplement 1C). To characterize the function of the genes occupied by OGT, we performed pathway enrichment analysis using iPAGE (Goodarzi et al., 2009). On CD only, OGT-decorated genes were involved in signal transduction, membrane potential, and calmodulin-dependent protein kinase activity (Figure 1G, left). Instead, genes targeted by OGT in the SD-only condition were enriched in G-protein-coupled receptor activity, synaptic target attraction, and transcription (Figure 1G, left). Finally, genes with differential OGT binding between SD/CD were enriched for regulatory/signaling and neural GO terms, including dendrite morphogenesis, neuron projection membrane, synaptic target attraction, signal transduction, pattern formation, and asymmetric cell division (Figure 1G right, for full iPAGE, GO term analysis see Figure 1—figure supplement 2). Interestingly, when we examined the pathways associated with genes found in OGT-associated blue and yellow chromatin intervals, only the blue genes revealed strongly significant enrichment in GO terms. These blue Polycomb chromatin genes were involved in GO terms such as dendrite morphogenesis (8.9E−08), axon guidance (7.88E−04), actin filament organization (2.45E−07), transcription factor activity (3.8E−07), MAPK kinase signaling (9.18E−05), and Transforming Growth Factor β pathway (0.0042). In contrast, the yellow genes only showed a small enrichment for plasma membrane, transcription factor activity (2.9E−01), basolateral plasma membrane (2.4E−01), and phosphonate metabolism (2.0E−01). Together, these experiments show that OGT resides on the chromatin of the sweet taste at open domains characterized by a small but significant diet sensitivity; genes associated with neural functions are abundant among the set with diet-dependent OGT binding but only enriched in the blue H3K27 Polycomb chromatin.

OGT and PRC2.1 share diet-sensitive chromatin sites

Our previous work showed that the epigenetic silencer PRC2.1 – specifically its H3K27m activity – was necessary and sufficient to drive sweet-taste plasticity in response to the nutrient environment (Vaziri et al., 2020). In the presence of high dietary sugar, PRC2.1 decreased chromatin accessibility and expression of transcription factors involved in synaptic function and signaling; these genes were located in blue-Polycomb H3K27m chromatin. Silencing these genes and their regulons lowered neural and behavioral responses to sweetness in high-sugar diet flies (Vaziri et al., 2020). Since OGT and PRC2.1 play a role in sweet-taste plasticity and OGT occupancy was enriched at blue Polycomb chromatin for neural functions, we asked whether there was an overlap in their occupancy.

A comparison of the peaks occupied by both Dam::Pcl (pink, Pcl is the recruiter for PRC2.1) and Dam::OGT (green) revealed a small number of shared intervals (Figure 2A, ~10%; Supplementary file 1). These 162 loci were enriched in the blue ‘Polycomb’ chromatin (p < 0.001, permutation test) and had lower expression levels in the Gr5a+ neurons (from TRAP experiment in Vaziri et al., 2020) compared to those bound by OGT alone (Figure 2B, purple vs. green), which include both Polycomb ‘blue’ and actively transcribed ‘yellow’ chromatin regions (Figure 1C; Filion et al., 2010). OGT × Pcl intervals had higher expression than those occupied by PRC2.1 alone, suggesting they could represent a subtype of Polycomb blue chromatin (Figure 2B, purple vs. pink). We next asked whether the dietary environment changed the association of OGT and Pcl at these loci. There was more OGT and Pcl at the OGT × Pcl shared sites in the SD condition compared to CD, and more OGT than Pcl was present at these sites in both diets (Figure 2C). Strikingly, chromatin accessibility at OGT × Pcl was markedly (50%) decreased on SD compared to CD (Figure 2D). This nutrient-dependent shift in accessibility was threefold higher at the shared loci compared to those bound by OGT alone (compare Figures 1F and 2D; also comparatively higher than those bound by PRC2.1 alone, Vaziri et al., 2020).

Figure 2. O-GlcNAc Transferase (OGT) and Polycomb Repressive Complex 2.1 (PRC2.1) mark nutrient-sensitive chromatin in the sweet-taste cells.

Figure 2.

(A) Diagram of the Targeted Dam-ID (TaDa occupancy, Dam::OGT green, and Dam::Pcl pink) and (CATaDa, accessibility, yellow) experiments analyzed in this figure. Overlap of log2(Dam::Pcl/Dam, pink) and log2(Dam::OGT/Dam, green) chromatin occupancy peaks (all peaks, peak calling: find_peaks, q<0.01). (B) The distribution in normalized reads (Transcript Per Million, TPM +1) for genes occupied by OGT (green), Pcl (pink), and OGT and Pcl (purple). Two-tailed t test, ****p<0.0001. (C) Average log2(Dam::OGT/Dam; left) and log2(Dam::Pcl/Dam) (right) signal on a CD (lighter shades) and SD (darker shades) diet centered at OGT + Pcl co-occupied peaks. (D) Average CATaDa signal on CD (lighter shade) and SD (darker shade) centered at OGT + Pcl co-occupied peaks. (E) (left) iPAGE pathway analysis of genes co-occupied by OGT and Pcl and (right) STRING interaction network of genes co-occupied by OGT + Pcl, colors represent GO terms from the pathway enrichment analysis.

GO term analysis of genes shared by OGT/Pcl targets revealed enrichment in regulatory pathways involved in sequence-specific DNA binding, including those implicated in neural differentiation, sodium channel regulator activity, Transforming Growth Factor β and Activin receptor signaling, and dendrite development (Figure 2E, left). 30% of the OGT × Pcl sites corresponded to genes encoding DNA-binding and regulatory factors, including two Homeobox transcription factors known to play a role in sweet-taste function and plasticity, cad and Ptx1 (Figure 2E, right) (Vaziri et al., 2020). Analysis of protein interactions between OGT × PRC2.1 genes (Szklarczyk et al., 2020) uncovered a Protein–Protein Interaction network enrichment (p < 1.0e−16) among DNA-binding factors (pink, p = 2.08e−09), Mitogen-Activated Protein Kinase (MAPK, blue, p = 0.00059), signal transduction (Transforming Growth Factor, TGF-β/Activin signaling, yellow), neuron projection (red outline, p = 4.95e−7), and response to stimuli (p = 7.15e−0.5). Consistent with OGT/Pcl targets being ~40% of OGT-associated peaks, the GO terms for the shared intervals were a subset of those enriched in the OGT-bound blue chromatin.

The catalytic activity of OGT is required for diet-induced taste plasticity

Our data show that OGT occupies the chromatin of the sensory neurons and that its binding is diet dependent at loci also bound by PRC2.1. To understand more about the mechanisms of OGT function and, thus, nutrigenomic signaling, we examined the role of OGT activity on taste plasticity using the Proboscis Extension Response (PER). As shown in Figure 3A, the fly proboscis houses the cell bodies and dendrites of the sensory neurons. When the taste sensilla in the labellum are stimulated with sucrose, the fly extends its proboscis to reach the sweet solution. The amount of proboscis extension for each concentration tested – 1 is a full extension, 0.5 a half, and 0 none – corresponds to the fly’s ability to taste and can be compared across genotypes and diets. As previously shown, consumption of SD for 7 days results in a decrease in PER for high (30%) and low (5%) concentrations of sucrose compared to animals that ate a control diet (Figure 3B, circles vs. squares, gray shades). However, knocking down OGT in the Gr5a+ sweet-sensing neurons resulted in flies with similar sweet sensitivity between the two diets (Figure 3B). Thus, OGT is required for diet-dependent sweet-taste plasticity. To ask if the catalytic activity of OGT was required for this taste phenotype, we compared the ability of protein null (OGT1) and catalytically dead mutants (OGTK872M) to rescue taste plasticity; both of these alleles are homozygous lethal and thus were tested in combination with w1118CS control flies. Neither mutant affected sweet-taste responses on a control diet, but both prevented the lower PER to sucrose observed in SD-fed control flies (Figure 3C). This argues that the catalytic activity of OGT is required for the effects of this enzyme on taste plasticity. Consistent with this, knocking down the antagonistic enzyme O-GlcNAcase (OGA), which removes the GlcNAc moiety from proteins, resulted in lower sweet-taste responses on CD (Figure 3D). We next asked if increasing the levels of OGT was sufficient to induce sweet-taste changes. OGT activity is linear across all levels of cellular UDP-GlcNAc, so increasing its levels also increases its activity (Hart, 2019). Overexpression of OGT in the Gr5a+ neurons resulted in sucrose responses on CD comparable to those observed in sugar diet-fed flies (Figure 3E). However, inhibiting the activity of OGT with the specific OGT Small Molecule Inhibitor-1 (OSMI) (Ortiz-Meoz et al., 2015; May et al., 2020) blocked the effects of OGT overexpression on sweet-taste responses (Figure 3E, right); this drug treatment had no effect on survival (Figure 4—figure supplement 1A). To finally test if the effects of SD on taste plasticity were dependent on OGT activity, we supplemented the CD and SD with OSMI during the entire duration of the diet exposure (7 days) and then tested PER to sucrose. Control (vehicle, Dimethyl Sulfoxide (DMSO)) flies exhibited a dulling of sweet-taste responses on SD (squares), but this decrease was entirely blocked by OSMI (Figure 3F); no effects were observed on a CD (circles). Thus, decreasing the activity of OGT, either with genetics or pharmacological tools, resulted in similar effects on taste plasticity, arguing that the activity of this enzyme plays an essential role in taste changes in response to the dietary environment.

Figure 3. O-GlcNAc Transferase (OGT) activity is necessary for taste plasticity in response to the sugar diet environment.

Figure 3.

(A) (top) Anatomy of the sensory system showing the cell bodies, dendrites, and axons of the sweet-sensing Gr5a+ neurons; (bottom) Diagram of the Proboscis Extension Response (PER). (B) Taste responses (y-axis) to stimulation of the labellum with 30, 10, and 5% sucrose (x-axis) in flies with knockdown of OGT (green) or controls (shades of gray) in flies fed a CD (circles) or SD (squares); n = 18–51. Two-way repeated measure analysis of variance (ANOVA), main effect of genotype: Gr5a>wcs p < 0.0001 (Tukey multiple comparison 30% p = 0.0008, 10% p = 0.0047, 5% p < 0.0001), Gr5a>OGT-RNAi p = 0.2657 (Sidak multiple comparison 30% p = 0.2792, 10% p = 0.9756, 5% p = 0.4883), OGT-RNAi>wcs (Sidak multiple comparison 30% p = 0.5923, 10% p = 0.0381, 5% p < 0.0001). (C) Taste responses (y-axis) to stimulation of the labellum with 30, 10, and 5% sucrose (x-axis) in flies with mutations in OGT (green) or controls (black) while on a control diet (CD, n = 16–26) or SD, n = 26–29. Two-way repeated measure ANOVA, main effect of genotype compared to wcs controls: ****p < 0.0001. Tukey multiple comparisons test, ****p < 0.0001, ***p < 0.001, **p < 0.01, *p < 0.05. (right) Diagram of OGT alleles: OGT1, protein null, OGTK872M catalytically dead. (D) Taste responses (y-axis) to stimulation of the labellum with 30, 10, and 5% sucrose (x-axis) in flies with knowdown of OGA (green) or controls (shades of gray) while on a control diet (CD), n = 31–47. Two-way repeated measure ANOVA, main effect of Gr5a>OGARNAi genotype compared to each control genotype: ****p < 0.0001. Tukey multiple comparisons test, ****p < 0.0001. (E) (left) Diagram of experiments with 10 μM OGT Small Molecule Inhibitor-1 (OSMI-1) in E and F; (right) taste responses (y-axis) to stimulation of the labellum with 30, 10, and 5% sucrose (x-axis) in flies with overexpression of OGT (green) or controls (shades of gray) while on a control diet (CD) supplemented with OSMI or vehicle, n = 19–22. Two-way repeated measure ANOVA, main effect of Gr5a>OGT genotype compared to each control genotype: ****p < 0.0001. Tukey multiple comparisons test, ****p < 0.0001 and *p < 0.05. (F) Taste responses (y-axis) to stimulation of the labellum with 30, 10, and 5% sucrose (x-axis) of age-matched male w1118cs flies on a CD (circle) or SD (square) diet with vehicle (DMSO) or OSMI. n = 14–17. Two-way repeated measure ANOVA, main effect of OSMI treatment p = 0.0089; Tukey multiple comparisons test for 30, 10, and 5% sucrose: (1) CD vs. SD (DMSO) p < 0.05, p = 0.0090, p = 0.0034 and (2) CD vs. SD (+OSMI-1), p > 0.05 at all concentrations. Data are shown as mean ± standard error of the mean (SEM).

OGT and PRC2.1 genetically interact to drive taste plasticity

To determine the effects of OGT catalytic activity on chromatin accessibility and PRC2.1 occupancy, we fed Gr5a>LT3-Dam; tubulin-GAL80ts and Gr5a>LT3-Dam::Pcl; tubulin-Gal80ts (Figure 4—figure supplement 1A) flies a CD or an SD supplemented with OSMI. Strikingly, OSMI treatment completely abolished the changes in chromatin accessibility observed with SD at OGT × Pcl sites (Figure 4A, compared to Figure 2D; Supplementary file 1), suggesting that OGT activity is necessary for diet-dependent dynamics at these loci. However, inhibition of OGT activity did not affect Pcl occupancy at these peaks, indicating that recruitment of PRC2.1 to these sites is largely independent of this metabolic enzyme (pink, Figure 4A). OSMI also had a mild effect on the occupancy of Dam::Pcl genomewide since the number (~1800), and identity (80%) of Dam::Pcl peaks were mainly the same with or without OSMI (Figure 4—figure supplement 1C). Only a smaller fraction of new PRC2.1-only peaks emerged with OSMI treatment, and the genes in these intervals were enriched in GO terms such as detection of chemical stimuli, DNA binding, and protein kinase activation (Figure 4—figure supplement 2). Thus, OGT activity is required for the diet-dependent decrease in chromatin accessibility but not PRC2.1 recruitment or occupancy, suggesting that other factors or events mediate these. However, we found that the catalytic activity of OGT was necessary for PRC2.1-mediated taste modulation. Overexpression of Pcl in the Gr5a+ neurons mimics the effects of SD on taste by decreasing responses to sucrose in flies fed a CD (Figure 4B, left) – a result dependent on the H3K27 methylation activity of this complex (Vaziri et al., 2020). However, OSMI blocked the effects of Pcl overexpression on sucrose responses compared to vehicle-fed flies (Figure 4B, right). These results place OGT upstream of PRC2.1 at both the molecular and behavioral levels. Since OGT is an enzyme known to modify proteins, we also asked whether its effects on taste plasticity were mediated, at least in part, through PRC2.1. Pclc429 mutations blocked diet-induced taste plasticity on SD (Figure 4C, pink vs. black, compare squares vs. circles), while Gr5a>OGT overexpression promoted a decrease in sucrose PER even on CD (Figure 4C, green vs. black, compare circles and squares). However, when Pclc429 mutants were combined with Gr5a>OGT, these flies failed to develop taste plasticity in response to SD without any effects on CD (Figure 4C purple). Thus, Gr5a>OGT;Pclc429 phenocopied Pclc429 mutants (compare pink and purple), suggesting that the effects of OGT act largely through PRC2.1. To further confirm these results and link them to the catalytic H3K27 methylation activity of PRC2.1, we treated Gr5a>OGT and control flies with a vehicle or the specific inhibitor of PRC2 (EEDi) while on CD (Qi et al., 2017). This manipulation restored normal taste responses to control levels in Gr5a>OGT flies (Figure 4D, compare right vs. left), consistent with what we observed with Gr5a>OGT; Pclc429 flies (Figure 4C). Together these results argue for a strong genetic interaction between OGT and PRC2.1.

Figure 4. O-GlcNAc Transferase (OGT) activity is necessary for chromatin and transcriptional dynamics in response to the sugar diet environment.

(A) (left) Average CATaDa signal on a CD (light yellow) and SD (dark yellow) with OSMI centered at OGT + Pcl peaks (compare to Figure 2D); (right) Average log2 Dam::Pcl/Dam signal on a CD (light pink) and SD (dark pink) with OSMI centered at OGT + Pcl peaks (compare to Figure 2). (B) Taste responses (y-axis) to stimulation of the labellum with 30, 10, and 5% sucrose (x-axis) of age-matched male Gr5a>Pcl (pink) and transgenic controls (shades of gray) on CD supplemented with vehicle (DMSO, n = 14–23) or 10 µM OSMI (n = 20–42). Two-way repeated measure analysis of variance (ANOVA): (1) DMSO, main effect of genotype (****p < 0.0001) and genotype x concentration (*p < 0.05); Tukey multiple comparisons test for 30, 10, and 5% sucrose concentrations: Gr5a>wcs vs. Gr5a>Pcl p = 0.0165, p = 0.0056, p = 0.0025; Pcl>wcs vs. Gr5a>wcs, ns. (2) OSMI: main effect of genotype p = 0.3194 and genotype × concentration p = 0.6893. (C) Taste responses (y-axis) to stimulation of the labellum with 30, 10, and 5% sucrose (x-axis) in Gr5a>OGT;Pclc429 (purple), Gr5a>OGT (green), Pclc429/+ (pink), and transgenic controls (gray) on CD or SD, n = 20–37. Two way repeated measure ANOVA, main effect of diet: ****p < 0.0001. Tukey multiple comparisons test, ****p < 0.0001 and *p < 0.05. (D) Taste responses (y-axis) to stimulation of the labellum with 30, 10, and 5% sucrose (x-axis) in Gr5a>OGT (green) and transgenic controls (shades of gray) on a CD supplemented with vehicle or 8 µM EEDi, n = 20–22. Two-way repeated measure ANOVA, main effect of Gr5a>OGT genotype compared to each control genotype: ****p < 0.0001. Tukey multiple comparisons test, ****p < 0.0001. (E) Log2fold (l2fc) of differentially expressed genes (DEGs) between SD/CD in w1118cs ± OSMI and Pclc429 SD/CD. (F) GO term analysis of the DEGs measured in the Gr5a+ neurons of flies fed a CD and SD + OSMI. (G) Taste responses (y-axis) to stimulation of the labellum with 30, 10, and 5% sucrose (x-axis) for a subset of DEGs in (E, purple circle) that show dependence on OGT and Polycomb Repressive Complex 2.1 (PRC2.1). n = 14–49. Purple, knockdown; red, overexpression; bold, direct OGT/PRC2.1 targets. Two-way repeated measure ANOVA, main effect of GAL4>wcs control genotype compared to each control genotype: ****p <0.0001. Tukey multiple comparisons test, ****p < 0.0001, ***p < 0.001, **p < 0.01, *p < 0.05. ACL, ATP Citrate Lyase; Irk1, inwardly rectifier potassium channel 1; daw, dawdle; cbt, cabut; exex, extra extra; syt-a, synaptotagmin alpha. Data are shown as mean ± standard error of the mean (SEM).

Figure 4.

Figure 4—figure supplement 1. Pcl occupancy at PRE and Pcl peaks with inhibition of O-GlcNAc Transferase (OGT) activity.

Figure 4—figure supplement 1.

(A) Effects of OSMI and Tretmetibin treatments on survival, n = 3 vials of 30 flies each. One-way analysis of variance (ANOVA) with Dunnett’s test. (B) Design of the TaDa and CaTaDa experiment in flies fed a CD + OSMI and SD + OSMI. (C) Principal component analysis of normalized log2(Pcl::Dam/Dam) flies on CD + OSMI (light pink) or SD + OSMI (dark pink). (D) Overlap of log2(Dam::Pcl/Dam) chromatin occupancy peaks in flies with (green outline) or without (pink) OSMI (find_peaks, q < 0.01).
Figure 4—figure supplement 2. Pathway enrichment analysis of the effects of OSMI on Dam::Pcl peaks.

Figure 4—figure supplement 2.

iPAGE identification of pathways depleted (blue) or enriched (red) compared to background gene list from the Dam::Pcl peaks shared (left) or different (right) between SD/CD with or without OSMI. Scale represents over-representation (red) or under-representation (blue) of genes within a specific bin for the corresponding GO term. Black outlined boxes represent q < 0.05.
Figure 4—figure supplement 3. Transcriptional responses to the dietary environment when O-GlcNAc Transferase (OGT) activity was inhibited.

Figure 4—figure supplement 3.

(A) Principal component analysis of Gr5a>UAS-Rpl3-3XFLAG flies on a control (light gray) or sugar (dark gray) diet for 7 days supplemented with OSMI-1. (B) Log2fold change (l2fc) (Gr5a IP/Input) for Gr5a, Gr64f, Gr64a, Ir56D, Gr32a, and Gr66a genes. (C) Volcano plot representing differential expression in the Gr5a+ neurons of age-matched male Gr5a>UAS-Rpl3-3XFLAG flies on a control or sugar diet for 7 days supplemented with OSMI. n = 3 replicates per condition. Genes with q < 0.1 (Wald test) are in green. (D) Log2fold change (l2fc) for candidate gene targets of Cad and Ptx1 at SD7 (teal), Pclc429 (pink), and OSMI fed flies at SD7 (green).
Figure 4—figure supplement 4. Pathway enrichment analysis of genes reverted or unchanged by OSMI.

Figure 4—figure supplement 4.

iPAGE identification of pathways depleted (blue) or enriched (red) compared to background gene list from genes with positive or negative log2 fold changes on SD + OSMI. Scale represents over-representation (red) or under-representation (blue) of genes within a specific bin for the corresponding GO term. Black outlined boxes represent q < 0.05.

To understand the consequences of the observed OGT-dependent shifts in chromatin accessibility, we isolated mRNAs associated with the ribosomes of the Gr5a+ cells using Translating mRNA Affinity Purification (TRAP) (Chen and Dickman, 2017) in flies fed a CD + OSMI and SD + OSMI. Principal component analysis revealed that most of the variation between samples was due to diet (Figure 4—figure supplement 3A); mRNAs specifically expressed in the Gr5a+ cells, such as the sweet-taste receptor genes (Gr5a, Gr64f, and Gr64a) and the fatty acids taste receptor Ir56D, were enriched in the Gr5a+ fraction compared to the input, while bitter receptor genes (Gr66a and Gr32a) were depleted (Figure 4—figure supplement 3B), indicating that the selection of Gr5a+ mRNAs was successful and comparable to our prior experiments (Vaziri et al., 2020). However, compared to the marked negative skew in gene expression we previously observed with a high-sugar diet, where 90% of genes had negative log2 fold changes, OSMI-differentially expressed genes (DEGs) showed a similar distribution in positive and negative changes (Figure 4—figure supplement 3C; Supplementary file 1; Vaziri et al., 2020). Indeed, further analyses revealed that OSMI treatment reverted (i.e., showed the opposite direction of change; q < 0.1, Wald test) or restored (practical equivalence test using a null hypothesis of a change of at least 1.5-fold and q < 0.05) the expression of 52% of the DEGs with SD/CD change (Figure 4E, gray are downregulated and red are upregulated), and that most of the genes changed with OSMI treatment (367) were also similarly affected by a loss of function Pclc429 mutation (Figure 4E). These genes were enriched in metabolic and neural processes, such as chemical synapse transmission, synaptic target attraction, cell differentiation, glucose metabolism, and detection of chemical stimuli (Figure 4G and Figure 4—figure supplement 4). Notable among these were the homeobox cad and Ptx1 and their regulons, which have been implicated in taste function and plasticity (Figure 4—figure supplement 3D; Vaziri et al., 2020), but also many whose effects of sweet-taste sensation are not known, like the Activin ligand dawdle (daw) and the transcription factor cabut (cbt). To functionally validate some of these new genes, we knocked down or overexpressed them (depending on their SD/CD log2 fold) in the Gr5a+ neurons and assayed sweet-taste function by PER (Figure 4F). This revealed a mild-to-moderate effect of these genes on sucrose sensation; interestingly, daw and Irk1 are direct targets of Pcl and OGT.

Together, these experiments place OGT and PRC2.1 in the same genetic pathway that directs diet-induced taste plasticity at the chromatin, transcriptional, and behavioral levels. They also argue that the activity of the metabolic sensor OGT may provide the nutrient-dependent context for PRC2.1-mediated changes in chromatin accessibility (but not PRC2.1 recruitment), while PRC2.1 may instead function as an effector of these chromatin and transcriptional changes.

The transcription factor Sr is part of the OGT–PRC2.1 nutrigenomic pathway

Our data show that OGT orchestrates responses to the dietary environment in the sensory neurons. To understand which other cellular context factors may cooperate with OGT and PRC2.1 to mediate taste plasticity, we examined the regulatory regions of OGT × Pcl and OGT × PREs (Polycomb Responsive Elements, DNA motifs to which Polycomb Proteins bind) loci for enriched cis-regulatory motifs (Figure 5—figure supplement 1A, B and Supplementary file 1; also, note that a TF may appear multiple times as dots in this graph because of different binding motifs). In this analysis, the highest log2 fold enrichments were for Polycomb Group proteins like PhoRC (1.018, p = 0.0099) and Trx-recruiter Trithorax-like (Trl, 1.972, p = 0.0099 and 0.803, p = 0.0099; Trx is antagonistic to PRC2.1), as well as transcription factors, such as the Zn-finger immediate early gene Stripe (Sr, homolog of activity-dependent human Early Growth Response 2, EGR2, alias Krox20), and the nutrient-sensitive factor Sterol-Responsive-Element Binding Protein (SREBP) (Supplementary file 1). To determine if they affected sweet taste, we measured the proboscis extension in response to sucrose when these genes were overexpressed or knocked down in the Gr5a+ neurons (Figure 5—figure supplement 1C). The only factor that affected sweet-taste responses across low and high sucrose concentrations was Sr, which also showed higher mRNA abundance in the sensory neurons of SD-flies (Figure 5—figure supplement 1D).

Sr is a conserved transcription factor induced by neural activity via the MAPK/ERK pathway (Chen et al., 2016; Gonzales et al., 2020; Beckmann and Wilce, 1997) and is essential for sensory nerve development and plasticity (Murphy et al., 1989; Duclot and Kabbaj, 2017). The MAPK pathway is sensitive to neural activity and nutrients (Robles-Flores et al., 2021; Papa et al., 2019); it is stimulated by mitogens, such as TGF-β/Activin signaling, which increase with high-sugar levels, eating, and neural activity in flies and mammals (Lavoie et al., 2020; Liu and Chen, 2022; Wilinski et al., 2019). Of note, OGT × Pcl co-occupied loci were enriched in MAPK/ERK targets (Figure 2E, blue). Enrichment for Sr cis-regulatory motifs was modest at OGT or Pcl-only loci (l2fc = 0.196 and 0.398, respectively; p < 0.001 in both cases via an approximate permutation test) but strong at genes bound by both factors (OGT × Pcl = 0.429 and OGT × PREs = 0.976, p < 0.001, permutation test) (Figure 5A; Supplementary file 1). When we compared the distribution of Sr sites around the regulatory regions of OGT × PRC2.1 genes (either together or separately), we found a marked bias around the TSS (Figure 5B, top), with enrichment of Sr-binding sites in the 500 bp window immediately preceding the TSS. In contrast, genes that OGT or PRC2.1 did not occupy, were depleted for Sr-binding sites at the TSS (Figure 5B, bottom). This suggests that Sr is enriched at the TSS of genes that are bound by OGT and PRC2.1. To this end, when we examined the expression of Sr-targets in the Gr5a+ neurons of flies on the two diets, we noticed that these genes had negative log2 fold changes on the sugar diet; this repression, however, was abolished by mutations in Pcl and by inhibition of OGT activity (Figure 5C, compare gray vs. pink and green, respectively), which hints toward functional cooperation between Sr and OGT/PRC2.1. To characterize the effects of higher Sr levels on neural activity and behavior, we used the UAS/GAL4 system to overexpress this gene in the Gr5a+ neurons of adult flies. Overexpression of Sr resulted in lower electrophysiological responses of the gustatory neurons to sucrose (Figure 5D, Mann–Whitney test, p = 0.001) as well as lower PER at both high and low sucrose concentrations (Figure 5E). This effect, however, was dependent on the catalytic activities of PRC2 and OGT. Indeed, overexpression of Sr in flies treated with OSMI (green) or with an inhibitor of PRC2 (pink, EEDi Vaziri et al., 2020) resulted in sucrose responses comparable to those of control flies (Figure 5F). Overall, these results argue for a role of Sr in taste plasticity in coordination with OGT and PRC2.1. Importantly, since OGT and PRC2.1 are not always found at TSS, the bias in Sr distribution at the TSS of ‘OGT/PRC2.1 regulated genes’ indicates that coordination between Sr and OGT/PRC2.1 may arise not from direct interactions but rather from two distinct paths of information flow, such as metabolism and neural activity.

Figure 5. The immediate early gene Sr is found at PRC2 × OGT genes and is involved in sweet-taste sensation.

(A) Log2fold (l2f) enrichment for Sr motifs at sites occupied by O-GlcNAc Transferase (OGT; green), Pcl (pink), or OGT + Pcl and OGT + PREs (purple), p < 0.0001. (B) Normalized distribution of Sr motifs along the regulatory regions 2500 bp up and downstream the transcriptional start site (TSS) for the genes in (A); the 500 bp immediately before each TSS are shaded in grey. Counts are normalized relative to the genome-wide expectation (derived by multiplying the number of potential target genes by the fractional coverage of Sr motifs on the genome); a score of 1.0 indicates the hypothetical genome-wide average overlap with Sr motifs and is shown as a red dashed line. (C) The distribution of RNA l2fc for genes that have Sr sites and are expressed in the Gr5a+ neurons of flies on a CD and SD in control flies or flies with mutations in Pcl or inhibition of OGT. q > 0.01. (D) Representative traces (left) and averaged neuronal responses to 25 mM sucrose stimulation from the L-type sensilla of Sr overexpression flies (blue) and controls (gray). n = 11. Mann–Whitney test: **p = 0.001. (E) Taste responses (y-axis) to stimulation of the labellum with 30, 10, and 5% sucrose (x-axis) in Sr overexpression flies (blue) and controls (gray). n = 22–38. Two-way repeated measure analysis of variance (ANOVA), main effect of genotype ****p < 0.0001 and genotype × concentration ****p < 0.0001; Tukey post-test for multiple comparisons: 30%: ***p = 0.0002 for Gr5a>Sr compared to each control, 10%: Gr5a>Sr vs. Gr5a>wcs p = 0.0025 and Gr5a>Sr vs. Sr >wcs ****p < 0.0001; 5%: ****p < 0.0001 for Gr5a>Sr compared to each control. Gr5a>wcs vs. Sr>wcs p > 0.05 at all concentrations. (F) Taste responses (y-axis) to stimulation of the labellum with 30, 10, and 5% sucrose (x-axis) in Sr overexpression flies (blue) and controls (gray) treated with the OGT inhibitor OSMI (green) or the PRC2 inhibitor EEDi (pink). n = 30. Two-way repeated measure ANOVA, main effect of genotype p = 0.2993 and p = 0.9146 and genotype × concentration p = 0.9293 and p = 0.9146, respectively. Data are shown as mean ± standard error of the mean (SEM).

Figure 5.

Figure 5—figure supplement 1. Enrichment analysis of cis-regulatory sites present in O-GlcNAc Transferase (OGT) and PREs.

Figure 5—figure supplement 1.

(A) Log2fold enrichment of TF cis-regulatory sites found at OGT + Pcl; blue q < 0.01. (B) Log2fold enrichment of TF cis-regulatory sites found at OGT + PREs. (C) Taste responses (y-axis) to stimulation of the labellum with 30, 10, and 5% sucrose (x-axis) for genes with cis-regulatory enrichment in A and B. n = 21–55. Two-way repeated measure analysis of variance (ANOVA), main effect of GAL4>wcs control genotype compared to each control genotype: ****p < 0.0001. Tukey multiple comparisons test, ****p < 0.0001, **p < 0.01, *p < 0.05. (D) Sr mRNA reads normalized as transcripts per million (TPMs) in the Gr5a+ neurons of flies on a CD (light gray) or SD (dark gray) for 7 days, q > 0.01. Data are shown as mean ± standard error of the mean (SEM).

The ERK pathway modulates taste adaptations in response to diet

Sr is the downstream transcriptional effector for the Extracellular-signal Regulated Kinase (ERK), a pathway stimulated by neural activity that plays a role in plasticity (Lavoie et al., 2020; Miningou and Blackwell, 2020; Thomas and Huganir, 2004; Figure 6A). We reasoned that ERK/EGR2 might provide sensory neurons with a specific context to drive dietary adaptations. To test this hypothesis, we examined the role of the kinase rolled (rl) – the ERK homolog in D. melanogaster – in sweet-taste and diet-induced taste plasticity.

Figure 6. The effect of the kinase rl/ERK on sweet taste depends on O-GlcNAc Transferase (OGT) activity.

(A) Diagram of the rl/ERK > Sr pathway, red sparks represent neural activity, and red outline represents activation. (B) Diagram of the two types of rl/ERK transgenes used. (C) Representative traces (left) and averaged neuronal responses to 25 mM sucrose of L-type sensilla in overexpression of wild-type (rlWT) or constitutively active (rlSem) rl/ERK in the Gr5a+ neurons (blue) and control (gray) on a CD. n = 11–23. One-way analysis of variance (ANOVA); Tukey’s multiple comparison test: ****p < 0.0001 for Gr5a/+ vs. Gr5a>rlSem, p = 0.279 for Gr5a/+ vs. Gr5a>rlWT, and *p = 0.018 for Gr5a>rlSem vs. Gr5a>rlWT. (D) Taste responses (y-axis) to stimulation of the labellum with 30, 10, and 5% sucrose (x-axis) in flies with overexpression of wild-type (rlWT) or constitutively active (rlSem) rl/ERK in the Gr5a+neurons (blue) and control (gray) flies on a CD + vehicle (DMSO). n = 24–27. Two-way repeated measure ANOVA, main effect of genotype p < 0.0001 and concentration × genotype p < 0.0001. Tukey multiple comparisons tests: ****p < 0.0001 for Gr5a>rlSem vs. all other genotypes at 30, 10, and 5% and p > 0.05 for all other comparisons at all concentrations. (E) Representative traces (left) and averaged neuronal responses to 25 mM sucrose of L-type sensilla in overexpression of wild-type (rlWT) or constitutively active (rlSem) rl/ERK in the Gr5a+ neurons (blue) and control (gray) on a CD + OSMI. n = 11–23. One-way ANOVA; Tukey’s multiple comparison test: p = 0.172 for Gr5a/+ vs. Gr5a>rlSem, p = 0.603 for Gr5a/+ vs. Gr5a>rlWT, and p = 0.034 for Gr5a>rlSem vs. Gr5a>rlWT. (F) Taste responses (y-axis) to stimulation of the labellum with 30, 10, and 5% sucrose (x-axis) in flies with overexpression of wild-type (rlWT) or constitutively active (rlSem) rl/ERK in the Gr5a+ neurons (blue) and control (gray) in flies fed a CD + OSMI. n = 26–33. Two-way repeated measure ANOVA, main effect of genotype p = 0.005; Tukey multiple comparisons tests: p > 0.05 for all other comparisons at all concentrations except for p < 0.0001 for Gr5a>rlSem vs. rlSem/wcs at 10% p = 0.0216. Effect of OSMI vs. vehicle: Gr5a>rlSem 30% p = 0.0012, 10% p = 0.0030, 5% p < 0.0001, and p < 0.05 for all other genotypes. Data are shown as mean ± standard error of the mean (SEM).

Figure 6.

Figure 6—figure supplement 1. rl/ERK is required for taste responses to sugar.

Figure 6—figure supplement 1.

(A) rl RNA reads normalized as transcripts per million (TPMs) in the Gr5a+ neurons of flies on a CD (light gray) or SD (dark gray) for 7 days. q > 0.01. (B) (left) Averaged neuronal responses to 25 mM sucrose from L-type sensilla in rl mutant (blue) and control (gray) flies. n = 6–10. Mann–Whitney test: p = 0.0005. (right) Taste responses (y-axis) to stimulation of the labellum with 30, 10, and 5% sucrose (x-axis) in rl mutant and control flies fed a CD. n = 26. Two-way repeated measure analysis of variance (ANOVA), main effect of genotype p < 0.0001; Dunn’s post-test **p < 0.01 and ***p < 0.001 vs. controls. (C) (left) Averaged neuronal responses to 25 mM sucrose from L-type sensilla in rl RNAi (blue) and control (gray) flies. n = 6–9. Mann–Whitney test: *p < 0.05. (right) Taste responses (y-axis) to stimulation of the labellum with 30, 10, and 5% sucrose (x-axis) in rl RNAi and control flies fed a CD. n = 24–27. Two-way repeated measure ANOVA, main effect of genotype ****p < 0.0001; Dunn’s post-test ****p < 0.001 vs. controls. Data are shown as mean ± standard error of the mean (SEM).

First, we observed that, as with Sr, the mRNA abundance of rl was higher in the Gr5a+ neurons of flies on SD, but this gene was not a direct target of OGT or PRC2.1 (Figure 6—figure supplement 1A). We tried several available antibodies against rl and activated (phosphorylated) rl to establish whether increased transcript levels also resulted in higher activation of this kinase; however, none of them resulted in a reliable signal in our hands. We thus turned to genetic tools to investigate whether higher rl expression or activity played a role in sweet-taste plasticity. To differentiate between these two possibilities, we expressed either a wild-type rl (rlWT, Figure 6B, top, Biggs et al., 1994) or constitutively active form of the kinase (rlSem Figure 6B, bottom, Oellers and Hafen, 1996) in the Gr5a+ neurons and tested neural and taste responses to sucrose. Overexpression of rlWT with Gr5a-GAL4 did not affect the electrophysiological responses of the sensory neurons to sucrose (Figure 6C, dark blue); however, expression of the active rlSem decreased neuronal responses to sucrose (Figure 6C, light blue). These activity phenotypes were reflected in the behavioral taste responses to sucrose, with rlWT flies having identical PER to sucrose as controls and rlSem showing reduced PER across high and low sucrose concentrations (Figure 6D, left vs. right; note that controls are shared here, plotted separately for clarity). Thus, rl activity, but not higher levels alone, was sufficient to affect sweet-taste plasticity. Not surprisingly, given the known function of rl/ERK in neural activity, we found that this kinase was also necessary for sweet-taste responses, as loss of function mutants and RNAi for rl had lower electrophysiological and behavioral responses to sucrose (Figure 6—figure supplement 1B, C). To test whether there was a synergetic interaction between rl and OGT, we repeated the same experiments in the presence of the OGT inhibitor OSMI. Strikingly, OSMI treatment almost entirely blocked the effects of rlSem on both neural and behavioral responses to sucrose while having no effect on rlWT flies (Figure 6E, F).

To characterize the function of the rl/Sr pathway on taste plasticity, we used Trametinib, a drug that inhibits ERK activation in animals (currently used for treating melanoma). At concentrations previously used in flies (15.6 μM) (Castillo-Quan et al., 2019; Slack et al., 2015), Trametinib blocked the effects of rlSem expression on sweet-taste responses (Figure 7—figure supplement 1A); this had no effect on survival (Figure 4—figure supplement 1A). Treatment with this ERK inhibitor also negated the effects of Sr overexpression on sucrose responses, resulting in flies with PER comparable to controls (Figure 7—figure supplement 1B), placing Sr downstream of ERK activation. Thus, Trametinib treatment efficiently blocks ERK signaling. To determine if the activity of the rl/Sr (ERK/EGR2) pathway was necessary for taste plasticity in response to the sugar diet environment, we fed flies a control or sugar diet with or without Trametinib for 7 days, then measured their neural and behavioral responses to sucrose. Exposure to a high-sugar diet decreased the electrophysiological (Figure 7A) and behavioral (Figure 7B) responses to sucrose. However, when rl activity was blocked with Trametinib, there was no decrease in neural responses or PER (Figure 7C and D). Of note, Trametinib had a minor but significant effect on sweet-taste activity (compare CD of Figure 7C with CD of Figure 7A), consistent with the observation that rl is necessary for normal sweet-taste function (Figure 6—figure supplement 1B, C). Together, these data indicate that the ERK pathway plays a critical role in the development of taste adaptations in response to diet and place its function upstream of OGT.

Figure 7. The rl > Sr pathway is important for taste adaptations in response to diet.

Representative traces (left) and averaged responses to 25 mM sucrose from L-type sensilla of flies fed a CD and SD (A), gray or Trametinib (C), blue. n = 11–14. Unpaired t-test: ***p = 0.0001 for CD vs. SD, and p = 0.486 for CD Trametinib vs. SD Trametinib. Taste responses to stimulation of the proboscis with sucrose in flies fed a CD and SD + vehicle (B), DMSO, gray or Trametinib (D), blue. PER, n = 20–33. PER: two-way repeated measure analysis of variance (ANOVA), main effect of diet, vehicle p < 0.0001 and Trametinib p = 0.4701; Tukey multiple comparison test: vehicle CD vs. SD 30% p = 0.421, 10% **p = 0.0017, and 5% ***p = 0.0002 and Trametinib CD vs. SD 30% p = 0.9702, 10% p = 0.4470, and 5% p = 0.9575. Effect of Trametinib: CD vehicle vs. CD Trametinib, 30% p = 0.1745, 10% p = 0.0108, 5% p = 0.0015; SD vehicle vs. SD Trametinib, 30% p = 0.4837, 10% p = 0.0228, 5% p = 0.2339. (E) A model for how O-GlcNAc Transferase (OGT), PRC2, and ERK orchestrate taste plasticity in response to a changing food environment. Boxes in pink describe the different steps of ‘information processing’ (see discussion). Data are shown as mean ± standard error of the mean (SEM).

Figure 7.

Figure 7—figure supplement 1. Effects of ERK inhibitor Trametinib on genetic manipulations of Sr and rl levels.

Figure 7—figure supplement 1.

(A) Taste responses (y-axis) to stimulation of the labellum with 30, 10, and 5% sucrose (x-axis) in flies fed a CD + Trametinib (blue) and with overexpression of rl (blue or controls in gray) n = 24–28. Two-way repeated measure analysis of variance (ANOVA), main effect of genotype p = 0.0206 and genotype × concentration p = 0.3671. (B) Taste responses (y-axis) to stimulation of the labellum with 30, 10, and 5% sucrose (x-axis) in flies fed a CD with or without Trametinib (blue) and with overexpression of Sr (blue, or controls in gray) n = 22–38. CD: two-way repeated measure ANOVA main effect of genotype ****p < 0.0001 and genotype × concentration p = 0.0037 with Sidak multiple comparison tests, 30%: Gr5a>Sr vs. Gr5a>wcs ***p = 0.0004 and Gr5a>Sr vs. Sr>wcs **p=0.0016; 10%: *p<0.05 for Gr5a>Sr compared to each control; 5%: Gr5a>Sr vs. Gr5a>wcs **p=0.0012 and Gr5a>Sr vs. Sr>wcs ***p=0.0003; Trametinib: two-way repeated measure ANOVA main effect of genotype p = 0.2192. Data are shown as mean ± standard error of the mean (SEM).

Discussion

Nutrigenomic signaling plays a role in health and disease by bridging the dietary environment with physiological adaptations. However, the molecular mechanisms and consequences of this type of nutrient sensing are still poorly understood. In particular, how nutrigenomic signals are integrated with cellular contexts has remained hard to define due to the lack of mechanistic nutrigenomic models (Müller and Kersten, 2003; Vaziri and Dus, 2021). In this work, we exploited the conserved phenomenon of diet-induced taste plasticity and the genetic tools of the D. melanogaster fly to answer these questions.

Here, we report that the metabolic enzyme OGT is associated with neural chromatin at introns and TSSs. While OGT-associated genes showed subtle but significant changes in chromatin accessibility in response to diet, these dynamics were much more robust at loci co-occupied by both OGT and the epigenetic silencer PRC2.1. At genes decorated by both factors, we observed sizable diet-dependent chromatin variations that were critically dependent on the catalytic activity of OGT. OGT activity was also necessary for the differential transcriptional and taste responses to the high-sugar diet. The OGT- and PRC2.1-bound nutrient-dependent loci were enriched for binding motifs for the activity-dependent transcription factor Sr at TSS, the effector of the ERK pathway. We show that this signaling pathway functions upstream of OGT/PRC2.1 to shape neural and behavioral taste responses to the dietary environment. We thus propose a model where a nutrigenomic pathway composed of OGT and PRC2.1 integrates information from the nutrient and cellular environment via ERK signaling to orchestrate sensory responses to diet (Figure 7E). Our data suggest that this integration occurs at the level of chromatin and modulates the expression of transcription factors and signaling regulators that further amplify and extend the reach of nutrigenomic signaling. Our findings thus shed light on how nutrigenomics contributes to neural plasticity and behavior.

OGT and chromatin dynamics

OGT is a conserved enzyme that catalyzes the transfer of UDP-GlcNAc to the serine and threonine residues of proteins (Hart, 2019; Olivier-Van Stichelen et al., 2017). Because UDP-GlcNAc synthesis by the HBP combines sugar, amino acid, nucleotide, and fatty acid metabolism, the levels of this metabolite, as well as the activity of the enzymes in this pathway, are inextricably linked to cellular metabolism and diet (Hart, 2019; Olivier-Van Stichelen et al., 2017). Higher HBP flux directly impacts OGT activity because the function of this enzyme is linear across a vast range of physiological UDP-GlcNAc concentrations. Because of this, OGT is recognized as a critical nutrient sensor in animal physiology, particularly in development, cancer, and metabolic disease (Hart, 2019; Olivier-Van Stichelen et al., 2017). More recently, its importance for neural function and plasticity has also been recognized, with studies implicating it in synapse maturation, neural excitability, activity, and plasticity (Butler et al., 2019; Ardiel et al., 2018; Lagerlöf et al., 2016; Su and Schwarz, 2017; Giles et al., 2019; Lagerlöf et al., 2017; Ruan et al., 2014; Hwang and Rhim, 2019; Li et al., 2019; May et al., 2019). Our group showed that a high-sugar diet acutely and chronically increased HPB activity in flies and played a role in diet-induced sensory plasticity (Wilinski et al., 2019; May et al., 2019).

OGT is a nucleocytoplasmic enzyme, and the GlcNAc modification is enriched in nuclear and synaptic proteins, which extends its reach on cellular physiology (Hart, 2019; Olivier-Van Stichelen et al., 2017). Although OGT is thought to play a role in gene regulation, only one study has shown its direct association with chromatin in murine embryonic stem cells (Vella et al., 2013). Here, we report that OGT also decorates neural chromatin in Drosophila melanogaster. Like in murine embryonic stem cells, OGT was enriched at introns and TSSs and primarily associated with transcriptionally active chromatin. However, we found that half of OGT intervals were also enriched at Polycomb repressive chromatin, consistent with previous reports that the GlcNAc modification is found at PREs, as well as on many Polycomb Group (PcG) proteins; OGT is also associated with PcG complexes to mediate Hox-gene repression (Hart, 2019; Olivier-Van Stichelen et al., 2017; Schuettengruber et al., 2017). On a high-sugar diet, there was a higher association of OGT with DNA but lower chromatin accessibility. However, the magnitude of these changes depended on what other regulatory and DNA-binding factors were found at OGT loci. At loci with PRC2.1 binding and Sr/EGR2 motifs, chromatin openness was markedly reduced in response to the high-sugar diet environment. This is the first study to show that OGT-associated chromatin is nutrient sensitive to the best of our knowledge. Importantly, this nutrient sensitivity was entirely dependent on the catalytic activity of OGT because it was abolished in the presence of the inhibitor OSMI. Interestingly, OGT activity had no effect on PRC2.1 association with co-occupied loci (and only a small effect at non-OGT loci, data not shown). The H3K27 methylation activity of PRC2.1 is required for changes in chromatin accessibility, including those that depend on diet in the sensory neurons (Schuettengruber et al., 2017; Vaziri et al., 2020). Thus, our data suggest that OGT activity affects the repressive action but not the recruitment of PRC2.1; we also demonstrate that the catalytic activity of PRC2.1 is required for the effects of OGT on taste plasticity.

These findings raise several important questions about the biochemical mechanisms of OGT action that our genetic system is poorly suited to address, but that will be important to define in future studies. First, what are the targets of OGT at nutrient-sensitive loci? Is OGT directly GlcNAcylating PRC2.1 to modify its repressive drive? Several studies have linked OGT activity with the stability, chromatin occupancy, or catalytic function of Polycomb Group Proteins (Hart, 2019; Olivier-Van Stichelen et al., 2017; Chu et al., 2014; Sakabe and Hart, 2010; Forma et al., 2018; Sui et al., 2020; Jiang et al., 2019; You et al., 2021; Decourcelle et al., 2020; Gambetta and Müller, 2014). Thus, converging evidence suggests that OGT impacts different aspects of PRC2.1 and PcG biology and is broadly consistent with our data. Connections between OGT and ERK have also been uncovered in the context of cancer and cell division, with studies showing that inhibition of ERK signaling decreases O-GlcNAcylation and vice versa (Zhang et al., 2015; Jiang et al., 2016) and that GlcNAcylation promotes ERK effects while OGT inhibition blocks them (Cork et al., 2018; Weiss et al., 2021; Lei et al., 2020). These findings are consistent with the effect and direction of the genetic interactions we observed between OGT and PRC2.1 and OGT and ERK, the direction of ‘information flow’ within the cell (Figure 7E), and the effects of our genetic manipulations. OGT could also affect chromatin accessibility by GlcNAcylating histones, although the function and effects of these histone modifications are still poorly understood (Gambetta and Müller, 2015; Hirosawa et al., 2018; Konzman et al., 2020; Olivier-Van Stichelen et al., 2017). Another outstanding question is how OGT is targeted to chromatin and whether this recruitment is dynamic and related to nutrient availability. For example, are there different local pools of OGT and GlcNAc in the nucleus vs. cytoplasm (or mitochondria) where OGT has been described? Because of the lack of functional fly OGT antibodies, we could not ask this question, but it is possible that the levels of OGT in the nucleus and cytoplasm change between diets. Finding answers related to the cellular compartmentalization of this metabolic enzyme and its targets will be an essential step in understanding nutrient signaling.

Sensors and effector mechanisms of nutrigenomic signaling in neural plasticity

In the case of the sweet-taste neurons, sugar directly activates the cells via receptor-dependent mechanisms and enhances OGT’s metabolic activity. Our data support the idea that integrating these two signals at the level of chromatin – a synergy almost entirely unique to these cells – is key for developing sensory plasticity. First, binding sites for the ERK effector Sr were among the most enriched at OGT × Pcl/PRE loci, consistent with our finding that OGT/Pcl/PRE loci were enriched in MAPK signaling (Figures 2 and 5); second, diet-driven changes in Sr regulons depended on the activity or presence of OGT and PRC2.1, and most importantly, the effects of rl/Sr (ERK/EGR2) on taste plasticity had strong epistatic interactions with OGT. Together, these molecular and functional data support the idea that the activity-dependent ERK pathway provides a relevant cellular context (likely neural activity) for adaptations to the nutrient environment. However, these sensing mechanisms must be turned into action to be effective. This is likely the role of PRC2.1 since the effects of ERK/EGR2 and OGT manipulations were dependent on the PRC2.1 function. Of note, only a small portion of the genes occupied by PRC2.1 is sensitive to diet and OGT activity, and our data show that PRC2.1 is not binding to new loci but instead tuning the output of those it is already bound to, likely via OGT instruction.

In the model we propose, metabolic and activity sensors integrate cellular information to promote changes in gene expression. But how are these actualized into physiological (in this case, neural) adaptations that underlie behavior or disease? This is one of the central and unresolved questions in nutrigenomics. Our model’s genetic and neural tractability provides a unique opportunity to get some answers. The 162 co-occupied loci identified were enriched for transcription and regulatory factors involved in cell proliferation, differentiation, signaling, and neural activity, as well as pathways implicated in neural plasticity. Many of these DNA-binding factors play essential roles during the development of sensory neurons to set their biophysical properties, such as Ptx1 and cad, but also affect adult taste plasticity. The regulons of these TFs include genes known to affect pre- and postsynaptic branching and structure, as well as synaptic physiology. Thus, our collective data indicate that this nutrigenomic pathway promotes taste adaptations, most likely by re-engaging developmental gene batteries, a mechanism that has been hypothesized to play a role in neural plasticity (Hobert, 2011; Marder and Prinz, 2002; Parrish et al., 2014; Vaziri et al., 2020). Whether this is a general rule of nutrigenomic signaling or something specific to these cells or neurons is yet to be determined; however, it is interesting to note that this is similar to how cancer cells exploit developmental networks for uncontrolled growth (Faubert et al., 2020; DeBerardinis and Chandel, 2016). On this note, many neural and psychiatric conditions show associations and connections with diet and metabolic states, including epilepsy, schizophrenia, bipolar, depression, Alzheimer’s, and Parkinson’s (Sarangi and Dus, 2021; Grigolon et al., 2020). Thus, uncovering nutrigenomic mechanisms in the brain could shed light on the etiology of these conditions and help design nutritional strategies to support people suffering from them; this is similar to how metabolic disorders like diabetes and cardiovascular disease are treated with a combination of drugs and nutrition.

Limitations

Although using sensory plasticity and fly gustatory neurons as a model to study nutrigenomic signaling brings unique advantages, it also has significant limitations. These primarily arise from the small number of cells (60) and the in vivo nature of our model. First, we cannot probe whether OGT, PRC2.1, and Sr/EGR2 physically interact or modify each other in these cells. We also could not probe whether SD enhances the presence of OGT protein in the nucleus compared to a control diet due to the lack of functional antibodies. Thus, evidence for our model arises from the combination of cell-specific molecular, genetic, and physiological data. Second, we only inferred that the loci with Sr/EGR2 motifs integrate activity due to the well-established function of the ERK pathway in activity-dependent plasticity; future studies should address this directly and compare the effects of acute vs. chronic nutrient influx.

Further, while inhibitors have allowed us to establish critical epistatic interactions and conduct dietary manipulations while bypassing developmental effects and genetic challenges, we cannot exclude that some of these effects may be non-cell autonomous. Integrating this model with biochemical approaches that preserve the appropriate activity and nutrient context would help address these critical questions. Finally, pathways beyond OGT, ERK, and PRC2.1 may also play a role in sensory plasticity.

Conclusions

In summary, we show that activity and nutrient-sensing mechanisms are integrated at the genomic level to promote neural adaptations to the food environment. In particular, our data reveal a central and instructional role for OGT and meaningful epistatic interactions with sensors (ERK) and effectors (PRC2.1). More generally, we put forth a model where cell and context specificity transforms ‘nutritional data’ – that is, variations in nutrient and metabolite levels – into nutritional information (Floridi, 2005), as shown in Figure 7E (pink boxes). This information is processed and interpreted by gene regulatory processes to make ‘decisions’ about responding to environmental challenges and carrying out physiological, neural, and behavioral changes. Thus, nutrigenomic mechanisms could provide a critical path for information flow in biological systems (Shannon, 1948; Reinagel, 2000; Smith, 2000; Fabris, 2009). A clear advantage could reside in their ability to amplify transient, and often minor, variations in nutrient and activity levels into strong reactions, which can be used to orchestrate responses to current and future environmental challenges. Future studies in this field will no doubt uncover fascinating insights about the rules of nutrigenomic communication: these discoveries will illuminate how nutrition and gene expression converge to shape cell physiology and provide us with new tools to promote wellness and diminish the burden of disease.

Materials and methods

Key resources table.

Reagent type (species) or resource Designation Source or reference Identifiers Additional information
Genetic reagent (D. melanogaster) w[1118]CS Other Gift from A Simon
Genetic reagent (D. melanogaster) UAST-sxc(Ogt)RNAiCLb38 PMID:24706800 Gift from C Lehner
Genetic reagent (D. melanogaster) Gr5a-GAL4 Bloomington Drosophila Stock Center BDSC: 57592
Genetic reagent (D. melanogaster) Tubulin-GAL80ts Bloomington Drosophila Stock Center BDSC: 7018
Genetic reagent (D. melanogaster) UAS-Pcl FlyORF FlyORF: F001897
Genetic reagent (D. melanogaster) Pclc429 Other Gift from N Liu
Genetic reagent (D. melanogaster) UAS-Rpl3-3XFLAG PMID:29194454 Gift from D Dickman
Genetic reagent (D. melanogaster) UAS-LT3-Dam Other Gift from AH Brand
Genetic reagent (D. melanogaster) UAS-LT3-Dam::Pcl PMID:33177090
Genetic reagent (D. melanogaster) UAS-LT3-Dam::OGT This paper See the Materials and methods
Genetic reagent (D. melanogaster) Gr64f-GAL4 Bloomington Drosophila Stock Center BDSC: 57669
Genetic reagent (D. melanogaster) UAS-Sr Bloomington Drosophila Stock Center BDSC: 26553
Genetic reagent (D. melanogaster) UAS-rlWT Bloomington Drosophila Stock Center BDSC: 36270
Genetic reagent (D. melanogaster) UAS-rlSem Bloomington Drosophila Stock Center BDSC: 59006
Genetic reagent (D. melanogaster) rl1 Bloomington Drosophila Stock Center BDSC: 386
Genetic reagent (D. melanogaster) rl RNAi Bloomington Drosophila Stock Center BDSC: 34855
Genetic reagent (D. melanogaster) OGA RNAi Bloomington Drosophila Stock Center BDSC: 41882
Genetic reagent (D. melanogaster) OGT1 PMID:26348912 Gift from D van Aalten
Genetic reagent (D. melanogaster) OGTK872M PMID:26348912 Gift from D van Aalten
Antibody Mouse monoclonal anti-Flag Sigma Cat#: F1804, RRID: AB_262044 3:50
Peptide, recombinant protein Dynabeads Protein G Thermo Fisher Scientific Cat#: 10004D
Peptide, recombinant protein T4 DNA ligase New England Biolabs Cat#: M0202S
Commercial assay or kit NEBuilder HiFi DNA Assembly kit New England Biolabs Cat#: E5520S
Commercial assay or kit ThruPLEX Kit Takara Cat#: 022818
Chemical compound, drug OSMI-1 Sigma Cat#: SML1621
Chemical compound, drug EED226 Axon Medchem Cat#: 2701
Chemical compound, drug Trametinib LC labs Cat#: T-8123
Chemical compound, drug TRIzol LS Reagent Thermo Fisher Scientific Cat#: 10296010
Software, algorithm Autospike3.9 Syntech http://www.ockenfels-syntech.com/products/signal-acquisition-systems-2/
Software, algorithm Prism 9 GraphPad RRID: SCR_002798
Software, algorithm Python Python RRID: SCR_008394

Fly husbandry, strains, and diets

All flies were grown and fed cornmeal food (Bloomington Food B recipe) at 25°C and 45–55% humidity under a 12 hr light/12 hr dark cycle (Zeitgeber time 0 at 9:00 AM) unless otherwise stated. Male flies were collected under CO2 anesthesia 1–3 days after eclosion and maintained in a vial that housed 35–40 flies. Flies were acclimated to their new vial environment for an additional 2 days and were moved to fresh food vials every other day. The GAL4/UAS system was used to express transgenes of interest using the Gustatory receptor 5a Gr5a-GAL4 transgene. For each GAL4/UAS cross, transgenic controls were made by crossing the w1118CS (gift from A. Simon, CS and w1118 lines from the Benzer laboratory) to GAL4 or UAS flies, sex-matched to those used in the GAL4/UAS cross. The fly lines used for this paper are listed in Supplementary file 1.

For all dietary manipulations, the following compounds were mixed into standard cornmeal food (Bloomington Food B recipe) (0.58 calories/g) by melting, mixing, and pouring new vials as in Musselman and Kühnlein, 2018 and Na et al., 2013. For the 30% sugar diet (1.41 calories/g), Domino granulated sugar (wt/vol) was added. Inhibitors were solubilized in 10% DMSO and added to the control o sugar diet at a total concentration of 10 μM for OSMI (Ortiz-Meoz et al., 2015; May et al., 2020), 8 μM for EEDi (Vaziri et al., 2020), and 15.6 μM for Trametinib (Castillo-Quan et al., 2019; Slack et al., 2015). Animals were assigned randomly to dietary groups. The sample sizes were determined based on standards in the field. No animal was excluded from any of the analyses.

Proboscis extension response

Male flies were food deprived for 18–20 hr in a vial with a Kimwipe dampened with Milli-Q filtered deionized water. PER was carried out as described in Shiraiwa and Carlson, 2007. Extension responses were recorded manually, and experimenters were blinded whenever possible. Experiments were replicated two to three times by two different experimenters.

Affinity purification of ribosome-associated mRNA (TRAP)

Male fly heads (300 per replicate, ~10,000 Gr5a+ cells) were collected using sieves chilled in liquid nitrogen and dry ice. Frozen tissue was then lysed as previously described (Chen and Dickman, 2017; Vaziri et al., 2020). From 10% of the total lysate, total RNA was extracted by TRIzol LS Reagent (Thermo Fisher Scientific, 10296010) for input. The remainder of the lysate was precleared by incubation with Dynabeads Protein G (Thermo Fisher Scientific, 10004D) for 2 hr and subsequently incubated with Dynabeads Protein G and an anti-Flag antibody (Sigma-Aldrich, F1804) at 4°C with rotation for 2 hr, then RNA was extracted from ribosomes bound to beads by TRIzol Reagent (Chen and Dickman, 2017).

Targeted DNA adenine methyltransferase identification (TaDa) and chromatin accessibility TaDa (CATada)

To generate the UAS-LT3-Dam::OGT construct, the coding region of the OGT gene was amplified from w1118CS animals with the primers listed below and assembled into the UAS-LT3-DAM plasmid (gift from A. Brand, University of Cambridge) using the NEBuilder HiFi DNA Assembly kit based on the manufacturer’s instructions (New England Biolabs). Transgenic animals were validated by reverse transcription PCR targeting the correct insert. UAS-LT3-Dam::Pcl was as previously described in Vaziri et al., 2020. The UAS-LT3-Dam::OGT, UAS-LT3-Dam::Pcl, and UAS-LT3-Dam line were crossed to the Gr5a-GAL4; tubulin-GAL80ts. All animals were raised and maintained at 20°C. Expression of Dam::OGT/Pcl and Dam was induced at 28°C for 18 hr. For all experiments, 300 heads of male and female flies were collected per replicate on dry ice by sieving. DNA was extracted following kit instructions (Invitrogen). To identify methylated regions, purified DNA was digested by Dpn I, followed by PCR purification of digested sequences. TaDa adaptors were ligated by T4 DNA ligase (NEB). Adapter ligated DNA was PCR amplified and purified according to the protocol (Marshall et al., 2016). Purified DNA was digested with Dpn II, followed by sonication to yield fragments averaging 300 base pairs. TaDa adaptors were removed from sonicated DNA by digestion followed by PCR purification, and purified sonicated DNA was used for library preparation (Vaziri et al., 2020; Marshall et al., 2016).

pUAST-Sxc.Forward gatctgGCCGGCGCaATGCATGTTGAACAAACACGAATAAATATG, pUAST-Sxc.Reverse gttccttcacaaagatcctTTATACTGCTGAAATGTGGTCCGGAAG.

Library preparation

Generation of RNA sequencing (RNA-seq) libraries was with the Ovation SoLo RNA-seq System for Drosophila (NUGEN, 0502-96). All reactions included integrated Heat-Labile Double-Strand Specific DNase treatment (ArcticZymes, catalog no. 70800-201). The DNA-sequencing libraries for TaDa were generated using the Takara ThruPLEX Kit (catalog no. 022818). For rat RNA-seq, libraries were prepared using the Nugen Ovation Model organism (Rat #0349-32) with 1/10th ERCC spike-in mix. These libraries were run on a NextSeq instrument using a HO 150 cycle cit (75 × 75 bp paired-end reads). All Drosophila libraries were sequenced on the Illumina NextSeq platform (High-output kit v2 75 cycles) at the University of Michigan Genomics Core facility.

High-throughput RNA-seq analysis

Fastq files were assessed for quality using FastQC (Andrews, Simon, and Others, 2010). Reads with a quality score below 30 were discarded. Sequencing reads were aligned by STAR (Dobin et al., 2013) to dmel-all-chromosomes of the dm6 genome downloaded from Ensembl genomes. Counting was conducted by HTSeq (Anders et al., 2015). Gene counts were used to call differential RNA abundance by DESeq2 (Love et al., 2014). A pipeline was generated from Wilinski et al., 2019. To determine the efficiency and cell specificity of the TRAP, pairwise comparisons were made between the Gr5a+-specific fraction and the input. For comparisons between dietary conditions, DESeq2 was only applied to the Gr5a+-specific IP condition. SD7 and Pclc429 datasets were analyzed from and described in Vaziri et al., 2020. A cutoff of q < 0.1 was used to call DEGs. To identify overlap between datasets GeneOverlap was used (Shen and Sinai, 2013).

High-throughput TaDa and CATaDa analysis

Fastq files were assessed for quality using FastQC (Andrews, Simon, and Others, 2010). Reads with a quality score below 30 were discarded. The damidseq_pipeline was used to align, extend, and generate log2 ratio files (Dam::OGT/Dam and Dam::Pcl/Dam) in GATC resolution as described previously (Marshall and Brand, 2015). Reads were mapped by Bowtie2 (Langmead and Salzberg, 2012) to dmel-all-chromosomes of the dm6 genome downloaded from Ensembl genomes, followed by read extension to 300 bp (or to the closest GATC, whichever is first). Bam output is used to generate the ratio file in bedgraph format. Bedgraph files were converted to bigwig and visualized in the UCSC Genome Browser. Principal components analysis plots between biological replicates were computed by multibigwigSummary and plotCorrelation in deepTools (Ramírez et al., 2016). Peaks were identified from ratio files using find_peaks (FDR <0.01) (Marshall and Brand, 2015) and as in Vaziri et al., 2020. Overlapping intervals or nearby intervals (up to 50 bp) were merged into a single interval using mergeBed in BEDtools (Quinlan and Hall, 2010). Intervals common in at least two replicate peak files were identified by Multiple Intersect in BEDtools and used to generate the consensus peaks (Quinlan and Hall, 2010). For CATaDa experiments, all analyses were performed similarly to those of TaDa with the exception that Dam only profiles were not normalized as ratios but shown as normalized binding profiles generated by converting bam files to bigwig files normalized to 1× dm6 genome as reads per genome coverage (Sequencing depth is defined as the total number of mapped reads times the fragment length divided by the effective genome size). Binding intensity metaplots were made by computing a matrix for specified regions (Ramírez et al., 2016). To determine the proportion of genes that fit within the various chromatin domain subtypes, we first matched Dam::OGT/Dam targets to coordinates identified by Filion et al., 2010 and then determined their gene count in each chromatin subtype (observed) compared to the whole genome (expected). Peak annotations were conducted using the HOMER annotatePeaks tool (Heinz et al., 2010) with the dm6 reference genome. In TaDa analysis, genes were considered targets of the factor being investigated if a peak existed anywhere on their length.

Pathway enrichment analysis

For all fly experiments, GO term enrichment analysis was performed using the iPAGE package (Goodarzi et al., 2009), using gene-GO term associations extracted from the Flybase dmel 6.08 2015_05 release. For all analyses, iPAGE was run in discrete mode. Independence filtering was deactivated for all discrete calculations. All other iPAGE settings default values. All shown GO terms pass the significance tests for overall information described in Goodarzi et al., 2009. For each term, bins that are outlined show especially strong contributions [p values such that a Benjamini–Hochberg FDR (Benjamini and Hochberg, 1995) calculated across that row yields q < 0.05].

Analysis of cis-regulatory enrichments

For each D. melanogaster DNA-binding protein motif available from the CIS-BP database (Weirauch et al., 2014), we scanned the D. melanogaster genome (dmel 6.08 2015_05 release) using the FIMO-binding site discovery tool [cite:doi:10.1093/bioinformatics/btr614]. Hits for each motif were retained as potential binding sites and used to calculate overlaps with other features (e.g., OGT of Pcl sites), as noted. Permutation tests to assess significance were performed through repeated application of the bedtools shuffle [cite: https://doi.org/10.1093/bioinformatics/btq033] command to obtain 100 resamplings (Supplementary file 1) or 1000 resamplings (Figure 4) of the feature location of interest, requiring non-overlap of the randomly placed features. For the analysis in Supplementary file 1, we separately considered each potential motif for each transcription factor extracted from the CIS-BP database (separate motifs for the same factor are denoted by the gene name followed by a ‘_#’ suffix, with # and integer). In the case of analysis of Sr-binding sites in Figure 4, we obtained a merged set of potential Sr-binding sites by filtering potential binding sites at a q value threshold of 0.1 (acting separately for each motif) and combining all of the locations that were counted as a potential binding site for any of the Sr motifs available from CIS-BP. Enrichments of overlaps with OGT, Pcl, and PRE sites were calculated by comparing the actual observed count of overlapping features with the mean overlap observed across 1,000 random samplings of the Sr motif locations (preserving the chromosome on which each motif is located during shuffling). For comparison of Sr motif locations with TSSs, we first identified the (strandedness-aware) start location of all ‘gene’, ‘mobile_genetic_element’, or ‘pseudogene’ features from the dmel6 Genbank annotations and then categorized all of these locations as ‘OGT/PRC2’ or ‘Not OGT/PRC2’ based on whether or not the gene was associated with an OGT, Pcl, or PRE location (see Supplementary file 1 for gene lists for each feature type). The density of Sr motif hits (as defined above) was then calculated as a function of position relative to the TSS.

Electrophysiology

Extracellular recording on labellar sensilla was performed using the tip recording method (Delventhal et al., 2014). Ten- to thirteen-day-old flies were anesthetized by short ice exposure. The reference electrode containing the Beadle–Ephrussi Ringer solution was inserted through the thorax into the labellum to immobilize the proboscis. The neuronal firing in L-type sensilla was recorded with a recording electrode (10–20 µm diameter) containing 25 mM sucrose dissolved in 30 mM tricholine citrate as an electrolyte. The recording electrode was connected to TastePROBE (Syntech), and electrical signals were obtained using the IDAC acquisition controller (Syntech). The signals were amplified (10×), band-pass-filtered (100–3000 Hz), and sampled at 12 kHz. Neuronal firing rates were analyzed by counting the number of spikes for a 500-ms period starting from 200 ms after contact using the Autospike 3.9 software. Experimenters were blinded in the initial characterization of the phenotypes and experiments were independently performed at least three times.

Data analysis and statistics

Statistical tests, sample size, and p or q values are listed in each figure legend. One- or two-way repeated measure analysis of variance with post hoc tests were used for all PER experiments. All behavioral data were tested for normality, and the appropriate statistical tests were applied if data were not normally distributed. For the RNA-seq expression datasets, we coupled our standard differential expression with a test for whether each gene could be flagged as ‘significantly not different’ – that is, a gene for which we can confidently state that no substantial change in expression occurred (rather than just a lack of evidence for change, as would be inferred from a large p-value on the differential expression test). Defining a region of practical equivalence as a change of no more than 1.5-fold in either direction, we tested the null hypothesis of a change larger than 1.5-fold using the gene-wise estimates of the SE in log2fold change (reported by Deseq2) and the assumption that the actual l2fcs are normally distributed. Rejection of the null hypothesis is evidence that the gene’s expression is not changed substantially between the conditions of interest. Python code for the practical equivalence test is in Source code 1. All data in the figures are shown as means ± standard error of the mean, ****p < 0.0001, ***p < 0.001, **p < 0.01, and *p < 0.05, unless otherwise indicated.

Data and material availability statement

All high-throughput data are available at the GEO repository: GSE188757 and GSE146245. LT3-Dam::OGT and Pcl flies are available upon request; all other fly lines are available in the BDSC database as shown in Supplementary file 1.

Acknowledgements

We thank the University of Indiana at Bloomington, the VDRC, the FLYORF stock collections, and all the investigators who shared fly lines with us. Julia Kuhn designed some of the graphics for the manuscript. We are grateful to Dr. Morteza Khabiri for assistance in the calculation of potential TF-binding sites. This work was funded by NIH R00 DK-97141, NIH 1DP2DK-113750, NIH R01DK130875, the Klingenstein-Simons Fellowship in the Neurosciences, the Rita Allen Foundation, and NSF CAREER 1941822 (all to MD), the Rackham Predoctoral Fellowship (to AV), NIH T32 DA007268 (DW), NIH K99 DK128539 (DW), NIH P30 DK089503 (MD and DW), and NIH R35GM128637 (to PLF).

Funding Statement

The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.

Contributor Information

Monica Dus, Email: mdus@umich.edu.

Dion K Dickman, University of Southern California, United States.

K VijayRaghavan, National Centre for Biological Sciences, Tata Institute of Fundamental Research, India.

Funding Information

This paper was supported by the following grants:

  • National Institute of Diabetes and Digestive and Kidney Diseases R00 DK-97141 to Monica Dus.

  • National Institute of Diabetes and Digestive and Kidney Diseases DP2DK-113750 to Monica Dus.

  • National Institute of Diabetes and Digestive and Kidney Diseases R01DK130875 to Monica Dus.

  • National Institute of Diabetes and Digestive and Kidney Diseases T32 DA007268 to Daniel Wilinski.

  • National Institute of Diabetes and Digestive and Kidney Diseases DK128539 to Daniel Wilinski.

  • National Science Foundation CAREER 1941822 to Monica Dus.

  • National Institute of Diabetes and Digestive and Kidney Diseases P30 DK089503 to Monica Dus.

  • National Institute of General Medical Sciences R35GM128637 to Peter L Freddolino.

  • Esther A. and Joseph Klingenstein Fund Fellowship in the Neurosciences to Monica Dus.

  • Rita Allen Foundation Scholar to Monica Dus.

  • Klingenstein-Simons Fellowship to Monica Dus.

  • Rackham Predoctoral Fellowship to Anoumid Vaziri.

Additional information

Competing interests

No competing interests declared.

No competing interests declared.

Author contributions

Conceptualization, Investigation, Methodology, Writing – review and editing.

Conceptualization, Resources, Formal analysis, Investigation, Visualization, Methodology, Writing – original draft.

Resources, Formal analysis, Writing – review and editing.

Formal analysis, Investigation, Writing – review and editing.

Data curation, Software, Investigation, Visualization.

Conceptualization, Formal analysis, Supervision, Funding acquisition, Investigation, Visualization, Writing – original draft, Project administration, Writing – review and editing.

Additional files

Supplementary file 1. Excel file with the analyses of the DAM and TRAP experiments.
elife-83979-supp1.xlsx (3.6MB, xlsx)
MDAR checklist
Source code 1. Python script to run the practical equivalence test (see methods).
elife-83979-code1.zip (4.5KB, zip)

Data availability

Sequencing data have been deposited in GEO under accession codes: GSE188757 and GSE146245. Analyzed omics data are included in Supplementary file 1.

The following dataset was generated:

Sung and Vaziri 2022. A nutrient information pathway links diet to taste. NCBI Gene Expression Omnibus. GSE188757

The following previously published dataset was used:

Vaziri A, Khabiri M, Genaw BT, May CE. 2020. Persistent Epigenetic Reprogramming of Sweet Taste by Diet. NCBI Gene Expression Omnibus. GSE146245

References

  1. Anders S, Pyl PT, Huber W. HTSeq -- a python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31:166–169. doi: 10.1093/bioinformatics/btu638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Andrews, Simon, and Others . FastQC: A Quality Control Tool for High Throughput Sequence Data. Cambridge, United Kingdom: Babraham Bioinformatics, Babraham Institute; 2010. [Google Scholar]
  3. Ardiel EL, McDiarmid TA, Timbers TA, Lee KCY, Safaei J, Pelech SL, Rankin CH. CaMK (CMK-1) and O-GlcNAc Transferase (OGT-1) Modulate Mechanosensory Responding and Habituation in an Interstimulus Interval-Dependent Manner in Caenorhabditis elegans. bioRxiv. 2018 doi: 10.1101/115972. [DOI]
  4. Beckmann AM, Wilce PA. Egr transcription factors in the nervous system. Neurochemistry International. 1997;31:477–510. doi: 10.1016/s0197-0186(96)00136-2. [DOI] [PubMed] [Google Scholar]
  5. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. 1995;57:289–300. doi: 10.1111/j.2517-6161.1995.tb02031.x. [DOI] [Google Scholar]
  6. Biggs WH, Zavitz KH, Dickson B, van der Straten A, Brunner D, Hafen E, Zipursky SL. The Drosophila rolled locus encodes a MAP kinase required in the sevenless signal transduction pathway. The EMBO Journal. 1994;13:1628–1635. doi: 10.1002/j.1460-2075.1994.tb06426.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bouché C, Serdy S, Kahn CR, Goldfine AB. The cellular fate of glucose and its relevance in type 2 diabetes. Endocrine Reviews. 2004;25:807–830. doi: 10.1210/er.2003-0026. [DOI] [PubMed] [Google Scholar]
  8. Butler AA, Sanchez RG, Jarome TJ, Webb WM, Lubin FD. O-Glcnac and EZH2-mediated epigenetic regulation of gene expression during consolidation of fear memories. Learning & Memory. 2019;26:373–379. doi: 10.1101/lm.049023.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Castillo-Quan JI, Tain LS, Kinghorn KJ, Li L, Grönke S, Hinze Y, Blackwell TK, Bjedov I, Partridge L. A triple drug combination targeting components of the nutrient-sensing network maximizes longevity. PNAS. 2019;116:20817–20819. doi: 10.1073/pnas.1913212116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chen X, Rahman R, Guo F, Rosbash M. Genome-wide identification of neuronal activity-regulated genes in Drosophila. eLife. 2016;5:e19942. doi: 10.7554/eLife.19942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Chen X, Dickman D. Development of a tissue-specific ribosome profiling approach in Drosophila enables genome-wide evaluation of translational adaptations. PLOS Genetics. 2017;13:e1007117. doi: 10.1371/journal.pgen.1007117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chu CS, Lo PW, Yeh YH, Hsu PH, Peng SH, Teng YC, Kang ML, Wong CH, Juan LJ. O-glcnacylation regulates EZH2 protein stability and function. PNAS. 2014;111:1355–1360. doi: 10.1073/pnas.1323226111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chyb S, Dahanukar A, Wickens A, Carlson JR. Drosophila gr5a encodes a taste receptor tuned to trehalose. PNAS. 2003;100 Suppl 2:14526–14530. doi: 10.1073/pnas.2135339100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cork GK, Tan EP, Thompson J, McGreal S, Machecek M, Kelsh J, Peterson K, Apte U, Slawson C. Sustained O‐glcnacylation amplifies ERK signaling. The FASEB Journal. 2018;32:S1. doi: 10.1096/fasebj.2018.32.1_supplement.673.20. [DOI] [Google Scholar]
  15. Dai Z, Ramesh V, Locasale JW. The evolving metabolic landscape of chromatin biology and epigenetics. Nature Reviews. Genetics. 2020;21:737–753. doi: 10.1038/s41576-020-0270-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Science Advances. 2016;2:e1600200. doi: 10.1126/sciadv.1600200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Decourcelle A, Very N, Djouina M, Loison I, Thévenet J, Body-Malapel M, Lelièvre E, Coqueret O, Leprince D, Yazidi-Belkoura IE, Dehennaut V. O-glcnacylation links nutrition to the epigenetic downregulation of UNC5A during colon carcinogenesis. Cancers. 2020;12:3168. doi: 10.3390/cancers12113168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Delventhal R, Kiely A, Carlson JR. Electrophysiological recording from Drosophila labellar taste sensilla. Journal of Visualized Experiments. 2014;1:e51355. doi: 10.3791/51355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. Star: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–21. doi: 10.1093/bioinformatics/bts635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Duclot F, Kabbaj M. The role of early growth response 1 (EGR1) in brain plasticity and neuropsychiatric disorders. Frontiers in Behavioral Neuroscience. 2017;11:35. doi: 10.3389/fnbeh.2017.00035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Fabris F. Shannon information theory and molecular biology. Journal of Interdisciplinary Mathematics. 2009;12:41–87. doi: 10.1080/09720502.2009.10700611. [DOI] [Google Scholar]
  22. Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368:eaaw5473. doi: 10.1126/science.aaw5473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Filion GJ, van Bemmel JG, Braunschweig U, Talhout W, Kind J, Ward LD, Brugman W, de Castro IJ, Kerkhoven RM, Bussemaker HJ, van Steensel B. Systematic protein location mapping reveals five principal chromatin types in Drosophila cells. Cell. 2010;143:212–224. doi: 10.1016/j.cell.2010.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Floridi L. Is semantic information meaningful data? Philosophy and Phenomenological Research. 2005;70:351–370. doi: 10.1111/j.1933-1592.2005.tb00531.x. [DOI] [Google Scholar]
  25. Forma E, Jóźwiak P, Ciesielski P, Zaczek A, Starska K, Bryś M, Krześlak A. Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells. PLOS ONE. 2018;13:e0198351. doi: 10.1371/journal.pone.0198351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Gambetta MC, Oktaba K, Müller J. Essential role of the glycosyltransferase sxc/ogt in polycomb repression. Science. 2009;325:93–96. doi: 10.1126/science.1169727. [DOI] [PubMed] [Google Scholar]
  27. Gambetta MC, Müller J. O-Glcnacylation prevents aggregation of the polycomb group repressor polyhomeotic. Developmental Cell. 2014;31:629–639. doi: 10.1016/j.devcel.2014.10.020. [DOI] [PubMed] [Google Scholar]
  28. Gambetta MC, Müller J. A critical perspective of the diverse roles of O-GlcNAc transferase in chromatin. Chromosoma. 2015;124:429–442. doi: 10.1007/s00412-015-0513-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ganguly A, Dey M, Scott C, Duong VK, Arun Dahanukar A. Dietary macronutrient imbalances lead to compensatory changes in peripheral taste via independent signaling pathways. The Journal of Neuroscience. 2021;41:10222–10246. doi: 10.1523/JNEUROSCI.2154-20.2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Gao J, Yang Y, Qiu R, Zhang K, Teng X, Liu R, Wang Y. Proteomic analysis of the OGT interactome: novel links to epithelial-mesenchymal transition and metastasis of cervical cancer. Carcinogenesis. 2018;39:1222–1234. doi: 10.1093/carcin/bgy097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Giles AC, Desbois M, Opperman KJ, Tavora R, Maroni MJ, Grill B. A complex containing the O-GlcNAc transferase OGT-1 and the ubiquitin ligase EEL-1 regulates GABA neuron function. The Journal of Biological Chemistry. 2019;294:6843–6856. doi: 10.1074/jbc.RA119.007406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Gonzales BJ, Mukherjee D, Ashwal-Fluss R, Loewenstein Y, Citri A. Subregion-specific rules govern the distribution of neuronal immediate-early gene induction. PNAS. 2020;117:23304–23310. doi: 10.1073/pnas.1913658116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Goodarzi H, Elemento O, Tavazoie S. Revealing global regulatory perturbations across human cancers. Molecular Cell. 2009;36:900–911. doi: 10.1016/j.molcel.2009.11.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Grigolon RB, Gerchman F, Schöffel AC, Hawken ER, Gill H, Vazquez GH, Mansur RB, McIntyre RS, Brietzke E. Mental, emotional, and behavioral effects of ketogenic diet for non-epileptic neuropsychiatric conditions. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2020;102:109947. doi: 10.1016/j.pnpbp.2020.109947. [DOI] [PubMed] [Google Scholar]
  35. Hanover JA, Krause MW, Love DC. The hexosamine signaling pathway: O-glcnac cycling in feast or famine. Biochimica et Biophysica Acta. 2010;1800:80–95. doi: 10.1016/j.bbagen.2009.07.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Hardivillé S, Hart GW. Nutrient regulation of signaling, transcription, and cell physiology by O-GlcNAcylation. Cell Metabolism. 2014;20:208–213. doi: 10.1016/j.cmet.2014.07.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Hart GW, Slawson C, Ramirez-Correa G, Lagerlof O. Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annual Review of Biochemistry. 2011;80:825–858. doi: 10.1146/annurev-biochem-060608-102511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Hart GW. Nutrient regulation of signaling and transcription. The Journal of Biological Chemistry. 2019;294:2211–2231. doi: 10.1074/jbc.AW119.003226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Hawkins M, Barzilai N, Liu R, Hu M, Chen W, Rossetti L. Role of the glucosamine pathway in fat-induced insulin resistance. The Journal of Clinical Investigation. 1997;99:2173–2182. doi: 10.1172/JCI119390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Molecular Cell. 2010;38:576–589. doi: 10.1016/j.molcel.2010.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Hirosawa M, Hayakawa K, Shiota K, Tanaka S, Laboratory of Cellular Biochemistry, Department of Animal Resource Sciences/Veterinary Medical Sciences, The University of Tokyo. Laboratory of Cellular Biochemistry, Department of Animal Resource Sciences/Veterinary Medical Sciences, The University of Tokyo. Waseda Research Institute for Science and Engineering, Waseda University. Laboratory of Cellular Biochemistry, Department of Animal Resource Sciences/Veterinary Medical Sciences, The University of Tokyo Histone O-glcnacylation and potential biological functions. OBM Genetics. 2018;2:1. doi: 10.21926/obm.genet.1803036. [DOI] [Google Scholar]
  42. Hobert O. Regulation of terminal differentiation programs in the nervous system. Annual Review of Cell and Developmental Biology. 2011;27:681–696. doi: 10.1146/annurev-cellbio-092910-154226. [DOI] [PubMed] [Google Scholar]
  43. Huang Z, Cai L, Tu BP. Dietary control of chromatin. Current Opinion in Cell Biology. 2015;34:69–74. doi: 10.1016/j.ceb.2015.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Hwang H, Rhim H. Acutely elevated O-GlcNAcylation suppresses hippocampal activity by modulating both intrinsic and synaptic excitability factors. Scientific Reports. 2019;9:7287. doi: 10.1038/s41598-019-43017-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Jiang M, Qiu Z, Zhang S, Fan X, Cai X, Xu B, Li X, Zhou J, Zhang X, Chu Y, Wang W, Liang J, Horvath T, Yang X, Wu K, Nie Y, Fan D. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling. Oncotarget. 2016;7:61390–61402. doi: 10.18632/oncotarget.11359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Jiang M, Xu B, Li X, Shang Y, Chu Y, Wang W, Chen D, Wu N, Hu S, Zhang S, Li M, Wu K, Yang X, Liang J, Nie Y, Fan D. O-Glcnacylation promotes colorectal cancer metastasis via the mir-101-O-glcnac/EZH2 regulatory feedback circuit. Oncogene. 2019;38:301–316. doi: 10.1038/s41388-018-0435-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Katada S, Imhof A, Sassone-Corsi P. Connecting threads: epigenetics and metabolism. Cell. 2012;148:24–28. doi: 10.1016/j.cell.2012.01.001. [DOI] [PubMed] [Google Scholar]
  48. Konzman D, Abramowitz LK, Steenackers A, Mukherjee MM, Na H-J, Hanover JA. O-Glcnac: regulator of signaling and epigenetics linked to X-linked intellectual disability. Frontiers in Genetics. 2020;11:605263. doi: 10.3389/fgene.2020.605263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Lagerlöf O, Slocomb JE, Hong I, Aponte Y, Blackshaw S, Hart GW, Huganir RL. The nutrient sensor OGT in PVN neurons regulates feeding. Science. 2016;351:1293–1296. doi: 10.1126/science.aad5494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Lagerlöf O, Hart GW, Huganir RL. O-glcnac transferase regulates excitatory synapse maturity. PNAS. 2017;114:1684–1689. doi: 10.1073/pnas.1621367114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Langmead B, Salzberg SL. Fast gapped-read alignment with bowtie 2. Nature Methods. 2012;9:357–359. doi: 10.1038/nmeth.1923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Lavoie H, Gagnon J, Therrien M. Erk signalling: a master regulator of cell behaviour, life and fate. Nature Reviews. Molecular Cell Biology. 2020;21:607–632. doi: 10.1038/s41580-020-0255-7. [DOI] [PubMed] [Google Scholar]
  53. Lei Y, Chen T, Li Y, Shang M, Zhang Y, Jin Y, Yu Q, Guo F, Wang T. O-Glcnacylation of PFKFB3 is required for tumor cell proliferation under hypoxia. Oncogenesis. 2020;9:21. doi: 10.1038/s41389-020-0208-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Li YH, Liu X, Vanselow JT, Zheng H, Schlosser A, Chiu JC. O-Glcnacylation of period regulates its interaction with clock and timing of circadian transcriptional repression. PLOS Genetics. 2019;15:e1007953. doi: 10.1371/journal.pgen.1007953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Liu H, Chen YG. The interplay between TGF-β signaling and cell metabolism. Frontiers in Cell and Developmental Biology. 2022;10:846723. doi: 10.3389/fcell.2022.846723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-Seq data with deseq2. Genome Biology. 2014;15:550. doi: 10.1186/s13059-014-0550-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Marder E, Prinz AA. Modeling stability in neuron and network function: the role of activity in homeostasis. BioEssays. 2002;24:1145–1154. doi: 10.1002/bies.10185. [DOI] [PubMed] [Google Scholar]
  58. Marshall S, Nadeau O, Yamasaki K. Dynamic actions of glucose and glucosamine on hexosamine biosynthesis in isolated adipocytes: differential effects on glucosamine 6-phosphate, UDP-N-acetylglucosamine, and ATP levels. The Journal of Biological Chemistry. 2004;279:35313–35319. doi: 10.1074/jbc.M404133200. [DOI] [PubMed] [Google Scholar]
  59. Marshall OJ, Brand AH. Damidseq_pipeline: an automated pipeline for processing DamID sequencing datasets. Bioinformatics. 2015;31:3371–3373. doi: 10.1093/bioinformatics/btv386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Marshall OJ, Southall TD, Cheetham SW, Brand AH. Cell-Type-Specific profiling of protein–DNA interactions without cell isolation using targeted DamID with next-generation sequencing. Nature Protocols. 2016;11:1586–1598. doi: 10.1038/nprot.2016.084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. May CE, Vaziri A, Lin YQ, Grushko O, Khabiri M, Wang QP, Holme KJ, Pletcher SD, Freddolino PL, Neely GG, Dus M. High dietary sugar reshapes sweet taste to promote feeding behavior in Drosophila melanogaster. Cell Reports. 2019;27:1675–1685. doi: 10.1016/j.celrep.2019.04.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. May CE, Rosander J, Gottfried J, Dennis E, Dus M. Dietary sugar inhibits satiation by decreasing the central processing of sweet taste. eLife. 2020;9:e54530. doi: 10.7554/eLife.54530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. May CE, Dus M. Confection confusion: interplay between diet, taste, and nutrition. Trends in Endocrinology and Metabolism. 2021;32:95–105. doi: 10.1016/j.tem.2020.11.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. McCluskey LP, He L, Dong G, Harris R. Chronic exposure to liquid sucrose and dry sucrose diet have differential effects on peripheral taste responses in female rats. Appetite. 2020;145:104499. doi: 10.1016/j.appet.2019.104499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Miningou N, Blackwell KT. The road to ERK activation: do neurons take alternate routes? Cellular Signalling. 2020;68:109541. doi: 10.1016/j.cellsig.2020.109541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Müller M, Kersten S. Nutrigenomics: goals and strategies. Nature Reviews. Genetics. 2003;4:315–322. doi: 10.1038/nrg1047. [DOI] [PubMed] [Google Scholar]
  67. Murphy P, Davidson DR, Hill RE. Segment-Specific expression of a homoeobox-containing gene in the mouse hindbrain. Nature. 1989;341:156–159. doi: 10.1038/341156a0. [DOI] [PubMed] [Google Scholar]
  68. Musselman LP, Kühnlein RP. Drosophila as a model to study obesity and metabolic disease. The Journal of Experimental Biology. 2018;221:jeb163881. doi: 10.1242/jeb.163881. [DOI] [PubMed] [Google Scholar]
  69. Na J, Musselman LP, Pendse J, Baranski TJ, Bodmer R, Ocorr K, Cagan R. A Drosophila model of high sugar diet-induced cardiomyopathy. PLOS Genetics. 2013;9:e1003175. doi: 10.1371/journal.pgen.1003175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Na J, Sweetwyne MT, Park ASD, Susztak K, Cagan RL. Diet-Induced podocyte dysfunction in Drosophila and mammals. Cell Reports. 2015;12:636–647. doi: 10.1016/j.celrep.2015.06.056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Oellers N, Hafen E. Biochemical characterization of rolledSem, an activated form of Drosophila mitogen-activated protein kinase. The Journal of Biological Chemistry. 1996;271:24939–24944. doi: 10.1074/jbc.271.40.24939. [DOI] [PubMed] [Google Scholar]
  72. Olivier-Van Stichelen S, Hanover JA. You are what you eat: O-linked N-acetylglucosamine in disease, development and epigenetics. Current Opinion in Clinical Nutrition and Metabolic Care. 2015;18:339–345. doi: 10.1097/MCO.0000000000000188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Olivier-Van Stichelen S, Wang P, Comly M, Love DC, Hanover JA. Nutrient-driven O-linked N-acetylglucosamine (O-glcnac) cycling impacts neurodevelopmental timing and metabolism. Journal of Biological Chemistry. 2017;292:6076–6085. doi: 10.1074/jbc.M116.774042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Ortiz-Meoz RF, Jiang J, Lazarus MB, Orman M, Janetzko J, Fan C, Duveau DY, Tan Z-W, Thomas CJ, Walker S. A small molecule that inhibits OGT activity in cells. ACS Chemical Biology. 2015;10:1392–1397. doi: 10.1021/acschembio.5b00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Papa S, Choy PM, Bubici C. The ERK and JNK pathways in the regulation of metabolic reprogramming. Oncogene. 2019;38:2223–2240. doi: 10.1038/s41388-018-0582-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Parrish JZ, Kim CC, Tang L, Bergquist S, Wang T, Derisi JL, Jan LY, Jan YN, Davis GW. Krüppel mediates the selective rebalancing of ion channel expression. Neuron. 2014;82:537–544. doi: 10.1016/j.neuron.2014.03.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Qi W, Zhao K, Gu J, Huang Y, Wang Y, Zhang H, Zhang M, Zhang J, Yu Z, Li L, Teng L, Chuai S, Zhang C, Zhao M, Chan H, Chen Z, Fang D, Fei Q, Feng L, Feng L, Gao Y, Ge H, Ge X, Li G, Lingel A, Lin Y, Liu Y, Luo F, Shi M, Wang L, Wang Z, Yu Y, Zeng J, Zeng C, Zhang L, Zhang Q, Zhou S, Oyang C, Atadja P, Li E. An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of Eed. Nature Chemical Biology. 2017;13:381–388. doi: 10.1038/nchembio.2304. [DOI] [PubMed] [Google Scholar]
  78. Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26:841–842. doi: 10.1093/bioinformatics/btq033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Ramírez F, Ryan DP, Grüning B, Bhardwaj V, Kilpert F, Richter AS, Heyne S, Dündar F, Manke T. DeepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Research. 2016;44:W160–W165. doi: 10.1093/nar/gkw257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Reed DR, Alhadeff AL, Beauchamp GK, Chaudhari N, Duffy VB, Dus M, Fontanini A, Glendinning JI, Green BG, Joseph PV, Kyriazis GA, Lyte M, Maruvada P, McGann JP, McLaughlin JT, Moran TH, Murphy C, Noble EE, Pepino MY, Pluznick JL, Rother KI, Saez E, Spector AC, Sternini C, Mattes RD. Nih workshop report: sensory nutrition and disease. The American Journal of Clinical Nutrition. 2020;113:232–245. doi: 10.1093/ajcn/nqaa302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Reinagel P. Information theory in the brain. Current Biology. 2000;10:R542–R544. doi: 10.1016/s0960-9822(00)00609-6. [DOI] [PubMed] [Google Scholar]
  82. Robles-Flores M, Moreno-Londoño AP, Castañeda-Patlán MC. Signaling pathways involved in nutrient sensing control in cancer stem cells: an overview. Frontiers in Endocrinology. 2021;12:627745. doi: 10.3389/fendo.2021.627745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Ruan H-B, Dietrich MO, Liu Z-W, Zimmer MR, Li M-D, Singh JP, Zhang K, Yin R, Wu J, Horvath TL, Yang X. O-Glcnac transferase enables AGRP neurons to suppress browning of white fat. Cell. 2014;159:306–317. doi: 10.1016/j.cell.2014.09.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Sakabe K, Hart GW. O-Glcnac transferase regulates mitotic chromatin dynamics. The Journal of Biological Chemistry. 2010;285:34460–34468. doi: 10.1074/jbc.M110.158170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Sarangi M, Dus M. Crème de la créature: dietary influences on behavior in animal models. Frontiers in Behavioral Neuroscience. 2021;15:746299. doi: 10.3389/fnbeh.2021.746299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Sartor F, Donaldson LF, Markland DA, Loveday H, Jackson MJ, Kubis H-P. Taste perception and implicit attitude toward sweet related to body mass index and soft drink supplementation. Appetite. 2011;57:237–246. doi: 10.1016/j.appet.2011.05.107. [DOI] [PubMed] [Google Scholar]
  87. Schuettengruber B, Bourbon H-M, Di Croce L, Cavalli G. Genome regulation by polycomb and trithorax: 70 years and counting. Cell. 2017;171:34–57. doi: 10.1016/j.cell.2017.08.002. [DOI] [PubMed] [Google Scholar]
  88. Sen SQ, Chanchani S, Southall TD, Doe CQ. Neuroblast-specific open chromatin allows the temporal transcription factor, hunchback, to bind neuroblast-specific loci. eLife. 2019;8:e44036. doi: 10.7554/eLife.44036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Shannon CE. A mathematical theory of communication. Bell System Technical Journal. 1948;27:379–423. doi: 10.1002/j.1538-7305.1948.tb01338.x. [DOI] [Google Scholar]
  90. Shen L, Sinai M. GeneOverlap: test and visualize gene overlaps. 1.1.1R Package Version. 2013 https://bioconductor.org/packages/devel/bioc/vignettes/GeneOverlap/inst/doc/GeneOverlap.pdf
  91. Shiraiwa T, Carlson JR. Proboscis extension response (PER) assay in Drosophila. Journal of Visualized Experiments. 2007;1:193. doi: 10.3791/193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Slack C, Alic N, Foley A, Cabecinha M, Hoddinott MP, Partridge L. The ras-erk-ETS-signaling pathway is a drug target for longevity. Cell. 2015;162:72–83. doi: 10.1016/j.cell.2015.06.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Smith Jm. The concept of information in biology. Philosophy of Science. 2000;67:177–194. doi: 10.1086/392768. [DOI] [Google Scholar]
  94. Su C, Schwarz TL. O-Glcnac transferase is essential for sensory neuron survival and maintenance. The Journal of Neuroscience. 2017;37:2125–2136. doi: 10.1523/JNEUROSCI.3384-16.2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Sui B, Chen D, Liu W, Wu Q, Tian B, Li Y, Hou J, Liu S, Xie J, Jiang H, Luo Z, Lv L, Huang F, Li R, Zhang C, Tian Y, Cui M, Zhou M, Chen H, Fu ZF, Zhang Y, Zhao L. A novel antiviral lncRNA, EDAL, shields a T309 O-GlcNAcylation site to promote EZH2 lysosomal degradation. Genome Biology. 2020;21:228. doi: 10.1186/s13059-020-02150-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Sung H, Vesela I, Driks H, Ferrario CR, Mistretta CM, Bradley RM, Dus M. High-sucrose diet exposure is associated with selective and reversible alterations in the rat peripheral taste system. Current Biology. 2022;32:4103–4113. doi: 10.1016/j.cub.2022.07.063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, Doncheva NT. The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Research. 2020;49:D605–D612. doi: 10.1093/nar/gkaa1074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Thomas GM, Huganir RL. Mapk cascade signalling and synaptic plasticity. Nature Reviews. Neuroscience. 2004;5:173–183. doi: 10.1038/nrn1346. [DOI] [PubMed] [Google Scholar]
  99. van Steensel B, Henikoff S. Identification of in vivo DNA targets of chromatin proteins using tethered dam methyltransferase. Nature Biotechnology. 2000;18:424–428. doi: 10.1038/74487. [DOI] [PubMed] [Google Scholar]
  100. Vaziri A, Khabiri M, Genaw BT, May CE, Freddolino PL, Dus M. Persistent epigenetic reprogramming of sweet taste by diet. Science Advances. 2020;6:46. doi: 10.1126/sciadv.abc8492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Vaziri A, Dus M. Brain on food: the neuroepigenetics of nutrition. Neurochemistry International. 2021;149:105099. doi: 10.1016/j.neuint.2021.105099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Vella P, Scelfo A, Jammula S, Chiacchiera F, Williams K, Cuomo A, Roberto A, Christensen J, Bonaldi T, Helin K, Pasini D. Tet proteins connect the O-linked N-acetylglucosamine transferase OGT to chromatin in embryonic stem cells. Molecular Cell. 2013;49:645–656. doi: 10.1016/j.molcel.2012.12.019. [DOI] [PubMed] [Google Scholar]
  103. Wang J, Liu R, Hawkins M, Barzilai N, Rossetti L. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature. 1998;393:684–688. doi: 10.1038/31474. [DOI] [PubMed] [Google Scholar]
  104. Wang QP, Lin YQ, Lai ML, Su Z, Oyston LJ, Clark T, Park SJ, Khuong TM, Lau MT, Shenton V, Shi YC, James DE, Ja WW, Herzog H, Simpson SJ, Neely GG. Pgc1Α controls sucrose taste sensitization in Drosophila. Cell Reports. 2020;31:107480. doi: 10.1016/j.celrep.2020.03.044. [DOI] [PubMed] [Google Scholar]
  105. Weirauch MT, Yang A, Albu M, Cote AG, Montenegro-Montero A, Drewe P, Najafabadi HS, Lambert SA, Mann I, Cook K, Zheng H, Goity A, van Bakel H, Lozano J-C, Galli M, Lewsey MG, Huang E, Mukherjee T, Chen X, Reece-Hoyes JS, Govindarajan S, Shaulsky G, Walhout AJM, Bouget F-Y, Ratsch G, Larrondo LF, Ecker JR, Hughes TR. Determination and inference of eukaryotic transcription factor sequence specificity. Cell. 2014;158:1431–1443. doi: 10.1016/j.cell.2014.08.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Weiss M, Anderluh M, Gobec M. Inhibition of O-glcnac transferase alters the differentiation and maturation process of human monocyte derived dendritic cells. Cells. 2021;10:12. doi: 10.3390/cells10123312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Wilinski D, Winzeler J, Duren W, Persons JL, Holme KJ, Mosquera J, Khabiri M, Kinchen JM, Freddolino PL, Karnovsky A, Dus M. Rapid metabolic shifts occur during the transition between hunger and satiety in Drosophila melanogaster. Nature Communications. 2019;10:4052. doi: 10.1038/s41467-019-11933-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Wise PM, Nattress L, Flammer LJ, Beauchamp GK. Reduced dietary intake of simple sugars alters perceived sweet taste intensity but not perceived pleasantness. The American Journal of Clinical Nutrition. 2016;103:50–60. doi: 10.3945/ajcn.115.112300. [DOI] [PubMed] [Google Scholar]
  109. You Z, Peng D, Cao Y, Zhu Y, Yin J, Zhang G, Peng X. P53 suppresses the progression of hepatocellular carcinoma via mir-15a by decreasing OGT expression and EZH2 stabilization. Journal of Cellular and Molecular Medicine. 2021;25:9168–9182. doi: 10.1111/jcmm.16792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Zhang X, Ma L, Qi J, Shan H, Yu W, Gu Y. Mapk/Erk signaling pathway-induced hyper-O-GlcNAcylation enhances cancer malignancy. Molecular and Cellular Biochemistry. 2015;410:101–110. doi: 10.1007/s11010-015-2542-8. [DOI] [PubMed] [Google Scholar]

Editor's evaluation

Dion K Dickman 1

Using Drosophila gustatory neurons as a model system, the authors provide important mechanistic insight into how nutrigenomic signaling encodes nutritional information into cellular changes. The authors expand previous work by showing that OGT is associated with neural chromatin at introns and transcriptional start sites and that diet-induced changes in chromatin accessibility were amplified at loci with the presence of both OGT and PRC2.1. The work also identifies Mitogen Activated Kinase as a critical mediator in this pathway. This is an elegant group of experiments revealing mechanisms for how nutrigenomic signaling triggers cellular responses to nutrients.

Decision letter

Editor: Dion K Dickman1
Reviewed by: Allan-Hermann Pool2

Our editorial process produces two outputs: (i) public reviews designed to be posted alongside the preprint for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.

Decision letter after peer review:

Thank you for submitting your article "Nutrigenomic Regulation of Sensory Plasticity" for consideration by eLife. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and K VijayRaghavan as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Allan-Hermann Pool (Reviewer #3).

The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.

Essential revisions:

There was relative consensus amongst the reviewers about the interest and potential importance of this study. In addition to the relatively straightforward controls and textual revisions detailed below, there were two major areas in which additional experiments are needed to strengthen and extend the impact of this study.

1) Perform additional genetic experiments (detailed below) to confirm and underscore the specificity of the pharmacological experiments. This might include a demonstration that the drug phenocopies the OGT enzymatic loss-of-function and related experiments.

2) Presenting analyses in non-sweet sensing neurons to strengthen the impact and specificity of the manipulations.

Reviewer #1 (Recommendations for the authors):

As the study currently stands, the proposed model is speculative, and a significantly revised approach and design would be needed to support the study's conclusions.

1) The genetic interactions of OGT with other genes (PRC, Plc, rolled) rely only on the treatment of the flies with a systemic pharmacological OGT activity inhibitor OSMI. But, it is not possible to draw strong and nuanced conclusions from the datasets that rely heavily of a systemic drug-based manipulation instead of precise genetic alleles. Ideally the authors would want to include the same DAM-ID experiments performed with a OGT enzymatic mutant versus a OGT-WT.

The authors are encouraged to ask what happens to PRC occupancy in CD and SD in tissue-specific KD of OGT using RNAi. If the RNAi reagent does not provide the authors a complete loss of function, they should consider using sgRNA-based KD approaches or generate a HA or GFP OGT knock-in line and then utilize degron based tissue-specific KD of OGT.

2) For the OSMI experiments, would the authors present evidence that the drug is specific to OGT and has no off-target effects? Alternatively, authors might want to consider presenting results with OGT KD or OGT enzyme specific mutants to correlate OSMI results with. These orthogonal and corroborative datasets would be required to bolster the conclusions.

3) This study is measuring the chromatin availability and determined that there was higher accessibility under CD conditions. Since OGT also has critical cytosolic roles, it would be important to determine if this is due to differences in nuclear: cytoplasmic localization of OGT or due to changes in OGT activity. To this end, I would recommend a western blot of Nuclear v. cytoplasmic fractions of OGT for flies on CD vs SD or imaging based approaches would be needed.

4) In Figure 2A, the authors describe a high correlation in chromatin binding sites between Pcl and OGT, concluding that the overlapping OGTXPRC2.1 regions are a critical subset for sweet tasting response. However, these overlapping regions are a rather small subset of sites, with the largest subset actually belonging the "yellow" H3K4/H3K36 euchromatin subset. It is unclear from this analysis why the authors chose to pursue the blue chromatin instead. It would be important to rank regulatory regions bound by DAM:OGT alone and DAM:Pcl alone to establish the primary regions of binding for both OGT and Pcl irrespective of each other. These regions can then be compared with the known sweet tasting genes to rank the relevant binding regions. Should there be other regions relevant to sweet taste that are not overlapping between OGT and Pcl that should be reported. This will also give readers a more comprehensive understanding about the role of Sr motifs and if this is a small but significant subset of genes regulated by OGT or comprise the majority of cis-regulatory regions controlled by OGT.

5) The authors use PCL as a proxy for PRC2.1 activity as it is the recruiter for PRC2.1. However, why wasn't DAM::PRC2.1 performed to directly compare to OGT? This data should be provided to show the overlap of PRC2.1 to Pcl or it should be explained in the results.

6) The authors findings are performed using flies overexpressing Pcl or OGT in Gr5a expressing cells for the TADA, PER experiments, and electrophysiology analysis. Because this analysis is based on an overexpression of the gene of interest, I believe it is important to repeat these experiments in flies overexpressing these genes in neurons unrelated to the sweet taste response- such as in the neighboring bitter taste neurons. This is especially a critical set of experiments to do, as the primary thesis of this study is about how each cell alters its nutrigenomic signaling in different cell types, but the analysis is primarily focused on DAM-ID datasets from overexpressed OGT in Gr5a. The study would be relevant if the authors did comparative analysis of OGT-PRC interactions in neurons that have different sensitivities or taste modalities to sugar.

7) The Proboscis extension response needs to be further elaborated on. The data plotted seems to be normalized but this is not explained in the paper. What is actually being measure? What is the N? If the data is normalized, then the authors should present raw data graphed in a supplemental figure at least.

8) Figure 4B seems misleading in the way it is plotted. Authors claim a bias of SR genes at the TSS in the PRC2.1 and OGT overlapping regions. However, the y axes are not to the same scale. In fact, the not OGT/PRC2 regions have much higher number of genes with SR motifs at every single position plotted on 4B. Specifically the strong statements findings in the results paragraph on lines 262-283 are not sufficiently supported and the authors are encouraged to revise this or move it to discussion.

9) Many of the experiments involved moving flies to OSMI or Trametinib diets. A caveat to this method is that this treatment will influence OGT/ERK in the fly globally. Because both OGT/ERK impact a number of critical biological processes, this makes the results difficult to interpret as impacts of taste sensing or due to the flies being generally unhealthy. It would be helpful to see fly survival on control, OSMI supplemented, and Trametinib diets to determine how detrimental these diet conditions are in general to the fly.

10) In general, the figure legends and methods are lacking in detail. For instance, in Figure 1F, are the GO terms for control diet comprised from all peaks listed or just the peaks unique to CD? Same question for the SD GO terms. Abbreviations are not elaborated in the legend or methods (ex: Figure 2B TPM) or lacking axis labels (ex: Figure 2D), etc. I suggest a thorough review of the methods and legend to add details necessary to interpret the results and make it possible to replicate experimental designs.

Reviewer #2 (Recommendations for the authors):

1. There are too many instances of non-technical phrases that are unclear/nonspecific. For example, "…OGT moonlights on the chromatin ….", or "… OGT decorates nutrient-sensitive …". These phrases should be replaced with more precise words, unless these phrases are common in the field and I am just unaware.

2. The Discussion section is overall too long and delves too much into the previous literature. It should be condensed and there should be more focus on the translational implications of the results.

Reviewer #3 (Recommendations for the authors):

– Almost all quantitative data in figures lack definition of variance measures (e.g. Panel 3C and E). Are data represented as mean +/I standard deviation, s.e.m.?

– Regarding setting up the problem – claiming "how nutritional information is transmuted to neural activity and behavioral changes remains elusive" is inaccurate – we know the receptors, increasingly many cells in the food intake regulatory circuit from sensory input to motor output in Drosophila.

– Methods refer to a python code on Github but no github repository is specified.

– Please also make the code for analyzing the DaMID and CaTaDa available online.

eLife. 2023 Mar 23;12:e83979. doi: 10.7554/eLife.83979.sa2

Author response


Essential revisions:

There was relative consensus amongst the reviewers about the interest and potential importance of this study. In addition to the relatively straightforward controls and textual revisions detailed below, there were two major areas in which additional experiments are needed to strengthen and extend the impact of this study.

1) Perform additional genetic experiments (detailed below) to confirm and underscore the specificity of the pharmacological experiments. This might include a demonstration that the drug phenocopies the OGT enzymatic loss-of-function and related experiments.

We have carried out several new genetic experiments to address the reviewers' concerns. In the revised manuscript, these experiments are shown in a new Figure 3 and revised Figure 4, and Figure 4-Supplement 1, Figure 5-Supplement 1, and Figure 6-Supplement 1; below, we outlined the experiments and explained the findings for the reviewers’ below before addressing the individual comments.

1A. OGT catalytic activity and OSMI-1

There are several published OGT mutant alleles, but we were only able to obtain two from the lab that generated them; we were told that all the others, including the UAS-versions which would have been useful for our experiments, were lost due to the mishandling of the fly stocks. We requested these stocks in early 2020 but were unable to get them for nearly a year due to the COVID lab restrictions in the UK; this is why we originally carried out the experiments with OSMI-1 once our own lab reopened at 20% capacity in July 2020-May 2021 since we had previously validated, used, and published with this reagent (May et al. 2020). In brief, OSMI-1 is a specific inhibitor of OGT developed by Harvard Medical School and the NIH and published in 2015 (Ortiz-Meoz et al. 2015); its inhibition is insensitive to UDP-GlcNAc concentration, and it doesn’t affect cell-surface glycosylation.

In data now added to Figure 3C, we compared OGTK872M, a full catalytically dead mutant, to the protein null OGT1 – please note that both of these are homozygous lethal, so here they were tested in heterozygous combination with w1118cs (wcs) control flies (Mariappa et al. 2015). As you can see in Figure 3, the heterozygous catalytically dead mutant, OGTK872M/+ (100% of OGT protein but only 50% catalytic activity, see diagram on the right), phenocopies the effects of protein null OGT1 allele (50% of protein with catalytic activity) in preventing diet-induced taste plasticity on a sugar diet (SD, squares). No effects were observed on a control diet (CD, circles). This provides genetic evidence for OGT activity being essential for taste changes in response to a sugar diet. Please note that as the diagram in Figure 3A now shows, proboscis extension response (PER) is measured from 1 (full extension) to 0 (no extension). Thus, the PER data shown in the manuscript is the raw data (mean +/-SEM) obtained from observing the flies during sucrose stimulation; it is not normalized (a comment of Reviewer 1). Importantly, the phenotype of OGTK872M/+ flies (wild-type taste on sugar diet) is similar to that of OGT RNAi targeted specifically to the Gr5a+ neurons (now Figure 3B). It is also identical to that of OSMI-1 treatment (now Figure 3F).

To further validate the role of OGT catalytic activity, we knocked down the gene for the antagonistic enzyme to OGT, O-GlcNAcase (OGA), which removes the GlcNAc moiety. If OGT catalytic activity were important, we would expect that interfering with removing the GlcNAc mark would mimic the effects of a sugar diet (and OGT overexpression) on taste. Figure 3 D shows that the knockdown of OGA in the Gr5a+ neurons resulted in a marked decrease in sucrose taste sensation in control-diet flies (Figure 3D). Thus, OGA knockdown recapitulates the effects of OGT overexpression and sugar-diet on sucrose taste, further validating the role of OGT activity in taste plasticity.

Finally, to link OSMI-1 to OGT function in our system, we tested the effects of OSMI-1 treatment in flies that overexpress OGT in the Gr5a+ neurons. As a reminder, expression of OGT in the Gr5a+ neurons results in taste depression on a control diet, recapitulating the effects of a sugar diet. Treatment with OSMI-1, however, inhibited the effects of OGT overexpression on sweet taste, as shown in Figure 3E. These results link the OGT overexpression phenotype to its catalytic activity. As reviewer 1 asked, we tested the effects of OSMI-1 and Tretmetinib on survival and found no effect (Figure 4-Supplement 1A).

Together, the experiments in the new Figure 3 provide solid evidence for the role of OGT catalytic activity in taste plasticity and support the design of the molecular experiments in Figure 4.

1B. Epistasis experiments

Reviewers 2 and 3 commented on the “elegant group of experiments” and “the thorough exploration of epistatic relationships between different players in the system.” These epistatic relationships would be very hard – and perhaps impossible– to parse out without the combination of genetic and pharmacological tools we used here. Since Reviewer 1 expressed concern about OGT, Pcl, and PRC2 interactions, we carried out additional genetic and pharmacological epistasis experiments, which we added to Figure 4 in the revised manuscript.

Figure 4C shows that the taste phenotype caused by OGT overexpression in the Gr5a+ neurons (green) is dependent on the presence of a functioning Pcl (pink and purple). And consistent with the function of Pcl as a PRC2.1 recruiter, Figure 4D shows that the ability of OGT to induce taste plasticity depends on the catalytically active PRC2 complex. These data provide genetic evidence for the data shown in the original version of the manuscript (now Figure 4B), where we rescued the effects of Pcl overexpression on taste with OSMI; they also suggest that PRC2 H3K27 methylation is likely the effector arm of this nutrigenomic signaling. A note in response to Reviewer 1: we manipulated Pcl instead of Ez because this manipulation is more specific. The PRC2 complex comes in many different “flavors,” all of which contain Ez as the H3K27m. Each of the PRC2 variants is characterized by a different recruiter, which targets the complex to specific regions of chromatin (i.e., Pcl has a Tudor domain which is thought to target PRC2.1, the PCl-containing PRC2, to actively transcribed chromatin). Thus, by manipulating Pcl, we can target a specific type of PRC2.1; in (Vaziri et al. 2020) we demonstrated that the other PRC2 variants are not involved in taste plasticity; in that manuscript, we also show that Pcl, Ez, Suz12, and Esc mutants phenocopy one another, and that the effects of Pcl on sweet taste are dependent on the catalytic activity of Ez.

Together these new data in Figure 4 place OGT and PRC2.1 in the same genetic pathway, and argue for a strong interaction between OGT, Pcl, and PRC2; these results also support those of the DAM-ID and TRAP molecular experiments, which show synergistic effects between these two players.

Additional experiments

We added data showing that Gr5a+-specific knockdown of the kinase rl (we previously only had mutant data) has marked effects on sucrose taste sensitivity (Figure 6-Supplement 1)

We also added a functional characterization as measured by proboscis extension response of some of the sugar diet DEGs that are dependent on OGT/Pcl as suggested by Reviewer 3 (Figure 4).

These genetic experiments make the conclusions of the manuscript stronger – we thus hope the reviewers find their concerns addressed.

2) Presenting analyses in non-sweet sensing neurons to strengthen the impact and specificity of the manipulations.

This study is a cell-specific investigation of nutrigenomic mechanisms in the Gr5a+ sweet-taste neurons; our intention was not to examine mechanisms across different cell types. However, we can understand the reviewers’ comments about this after rereading the abstract and introduction. As such, we have rewritten part of the manuscript to better introduce the rationale behind the study as the integration of metabolic signaling and cellular contexts. We hope this is now an improved framing for the study rationale.

About analyzing the effects of diet on other cells, no doubt this is an interesting question. However, this also signifies embarking on a completely separate project that would take, optimistically speaking, at least one year to complete and require a budget of ~ $130,000 (see breakdown). Thus, this suggestion doesn’t seem in line with the peer review and editorial philosophy of eLife. Carrying out this new project would result in an additional 6-7 figures but would not fundamentally change the conclusion of the current work; in fact, it may even take away from the targeted integration of molecular biology and neuroscience we have tried to achieve.

Moreover, talking about the practicality of this proposal, we do not have such an unallocated budget, and so this new project would require us first to generate preliminary data on the bitter neurons, then write a grant proposal to fund it; as you can appreciate, this would take longer than a year, especially since we do not even know if the bitter gustatory neurons are affected by a high-sugar diet. Beyond this, looking at the bitter neurons would do little to prove specificity. If we found no effects of this pathway on the activity of the bitter neurons, it wouldn’t establish that the changes in the sweet taste neurons are specific. In fact, the same pathway could be acting in some of the other thousands of fly circuits that were not investigated (Black swan effect). If we did find that OGT/PRC2.1/Sr play a role in the bitter neurons, it would also do little to disprove specificity since their targets would likely be different because the sets of genes expressed in these two sensory neurons are different. By analogy, the protein sensor mTOR is expressed and active in every cell, where it modulates some of the same targets (i.e., S6K); however, the effects of the pathway may be different due to the distinct metabolic and genetic idiosyncrasies of cells, as well as cellular compartments. This lack of specificity doesn’t mean that mTOR is not important or unspecific. Finally, we would like to note that we have tested the effects of manipulating OGT levels in other neurons (dopamine and Mushroom Body Output Neurons) without effects on behavior or neural responses (May et al. 2020; Pardo-Garcia et al. 2022); based on these, OGT doesn’t seem to affect neurons indiscriminately.

Budget ~ $129,000

Salary and fringe benefits for PD for 10 calendar months: $75,000 (2 months behavior experiments, 2 months training for molecular biology experiments and troubleshooting in new neurons, 4 months growing flies and conducting experiments, 2 months data analysis and visualization)

DAM ID: $16,0000, Pcl:dam and OGT:dam in CD and SD, with and without OSMI x 4 biological replicates per condition = 32 samples @ $500 per sample (UM Genomics core)

TRAP: $16,0000 Pcl mutant and OSMI in CD and SD x 4 biological replicates per condition + sequencing input = 32 samples @ $500 per sample (UM Genomics core)

Animals' food and maintenance: $ 5,000, $500 per person/10 months

Reagents: = $17,000, including sequencing kit (32 reactions = $6,000) x 2 = $12,000, and other reagents such as drugs and plastic

Note that this PD would have to be hired and retrained. The first author of the manuscript who carried out the molecular experiments graduated in Dec 2021 but failed to pass on the technical knowledge due to COVID restrictions at the UM: we were completely shut down until July 2020, and at 20% capacity from March 2020 to July 2021 (people also couldn’t work together to show techniques), and no new people joined the lab in 2020-2022 (most of the 2021 grad student class deferred to 2022 and no PD candidates apply).

Reviewer #1 (Recommendations for the authors):

As the study currently stands, the proposed model is speculative, and a significantly revised approach and design would be needed to support the study's conclusions.

1) The genetic interactions of OGT with other genes (PRC, Plc, rolled) rely only on the treatment of the flies with a systemic pharmacological OGT activity inhibitor OSMI. But, it is not possible to draw strong and nuanced conclusions from the datasets that rely heavily of a systemic drug-based manipulation instead of precise genetic alleles. Ideally the authors would want to include the same DAM-ID experiments performed with a OGT enzymatic mutant versus a OGT-WT.

The authors are encouraged to ask what happens to PRC occupancy in CD and SD in tissue-specific KD of OGT using RNAi. If the RNAi reagent does not provide the authors a complete loss of function, they should consider using sgRNA-based KD approaches or generate a HA or GFP OGT knock-in line and then utilize degron based tissue-specific KD of OGT.

2) For the OSMI experiments, would the authors present evidence that the drug is specific to OGT and has no off-target effects? Alternatively, authors might want to consider presenting results with OGT KD or OGT enzyme specific mutants to correlate OSMI results with. These orthogonal and corroborative datasets would be required to bolster the conclusions.

Response to 1 and 2 (as point 1 in the author’s recommendations):

In data now added to Figure 3C and added here for the reviewer’s convenience, we show that heterozygous catalytically dead mutants, OGTK872M/+ ((Mariappa et al. 2015) 100% of OGT but only 50% cat activity, see diagram on the right), phenocopies the effects of protein null OGT1 allele (50% of protein with catalytic activity) in preventing diet-induced taste plasticity on a sugar diet (SD). No effects were observed on a control diet (CD). This shows genetic evidence for OGT activity being essential for taste changes in response to a SD. Please note that as the diagram in Figure 3A now shows, proboscis extension response (PER) is measured from 1 (full extension) to 0 (no extension). Thus, the PER data shown in the manuscript is the raw data (mean +/-SEM) obtained from observing the flies during sucrose stimulation; it is not normalized (see below for full response to this comment). Importantly, the phenotype of OGTK872M/+ flies (wild-type taste on sugar diet) is similar to that of OGT RNAi targeted specifically to the Gr5a+ neurons (now Figure 3B). It is also identical to that of the OSMI-1 treatment (now Figure 3E). OSMI-1 is a specific inhibitor of OGT developed by Harvard Medical School and the NIH and published in 2015 (Ortiz-Meoz et al. 2015); its inhibition is insensitive to UDP-GlcNAc concentration, and it doesn’t affect cell-surface glycosylation. We had previously used OGT in (May et al. 2020).

If OGT catalytic activity were important, we would expect that interfering with the removal of GlcNAcylation would mimic the effects of a sugar diet and OGT overexpression on taste. We tested this possibility by knocking down the antagonistic enzyme to OGT, O-GlcNAcase (OGA), which removes the GlcNAc moiety only in the Gr5a+ neurons. This resulted in a marked decrease in sucrose taste sensation in control-diet flies (Figure 3D), mimicking the effects of OGT overexpression and sugar diet and further validating the role of OGT activity.

To further validate these findings, we tested the effects of OSMI-1 treatment in flies that overexpress OGT in the Gr5a+ neurons. As a reminder, expression of OGT in the Gr5a+ neurons results in taste depression on a control diet, mimicking the effects of a sugar diet. Treatment with OSMI-1, however, inhibited the effects of OGT overexpression on taste, as shown in Figure 3 E. These results link the OGT overexpression phenotype to its catalytic activity.

Together, the experiments in the new Figure 3 provide further evidence for the role of OGT catalytic activity in taste plasticity.

We disagree with the comment that we rely solely on pharmacological manipulations; in fact, we use cell-specific – pharmacological and dietary interventions. Indeed, Reviewers 2 and 3 praised our approaches by saying: “This is an elegant group of experiments revealing mechanisms for how nutrigenomic signaling triggers cellular responses to nutrients” and “Strengths: the thorough exploration of epistatic relationships between different players in the system.” All of our experiments combine genetic manipulations in combination with dietary and/or pharmacological treatments to show that molecular, neural, and behavioral taste phenotypes arise only in specific contexts, so no single phenotype occurs due to nonspecific manipulations. Without this approach, most of these epistatic relationships would be largely inaccessible in this system. We have also used a combination of both genetic and pharmacological tools to implicate not only genes but also their function (i.e., enzymatic activity) to nutrient-specific effects. Third, we established causality and relationship by inducing and rescuing the molecular, behavioral, and electrophysiological phenotypes. Thus, our model is based on a combination of direct and indirect data (genetic manipulations are by nature inferential) obtained from a controlled and careful set of experiments.

We could spend the next 6+ months trying to generate cell-specific alleles of OGT, which could bring their own unspecific effect, such as development and compensatory effects. However, this would only marginally add to the story now that we have added additional characterizations. In particular, we carried out additional genetic and pharmacological epistasis experiments, which we added to Figure 4. Here, we show that the taste phenotype caused by OGT overexpression in the Gr5a+ neurons entirely depends on the presence of Pcl. This provides genetic evidence for the data in the original manuscript version (now Figure 4B), where we rescued the effects of Pcl overexpression with OSMI-1.

We manipulated Pcl instead of Ez because this manipulation is more specific. The PRC2 complex comes in many different “flavors,” all of which contain Ez. Each of the PRC2 variants is characterized by a different recruiter, which targets the complex to specific regions of chromatin (i.e., Pcl has a Tudor domain which is thought to target PRC2.1, the PCl-containing PRC2, to actively transcribed chromatin). Thus, by manipulating Pcl, we can target a specific type of PRC2.1, and as we showed in, (Vaziri et al. 2020), the other PRC2 variants do not play a role in taste plasticity; in that manuscript, we also show that Pcl, Ez, Suz12, and Esc mutants phenocopy one another, and that the effects of Pcl on taste are indeed dependent on the catalytic activity of Ez. Here we took a similar approach and showed that OGT expression requires not only Pcl, but a catalytically active PRC2 to mediate its effect on taste plasticity (Figure 4D).

Together the new Figure 4 experiments place OGT and PRC2.1 in the same genetic pathway, indicating a strong interaction between OGT, Pcl, and PRC2, and support the results of the DAM-ID and TRAP molecular experiments, which show synergistic effects between these players.

Finally, we added data showing that Gr5a+-specific knockdown of the kinase ERK (we previously only had mutant data) has marked effects on sucrose taste sensitivity (now in Figure 6-Supplement 1C).

The addition of these genetic experiments makes the manuscript stronger and hope the reviewer finds their concerns addressed.

3) This study is measuring the chromatin availability and determined that there was higher accessibility under CD conditions. Since OGT also has critical cytosolic roles, it would be important to determine if this is due to differences in nuclear: cytoplasmic localization of OGT or due to changes in OGT activity. To this end, I would recommend a western blot of Nuclear v. cytoplasmic fractions of OGT for flies on CD vs SD or imaging based approaches would be needed.

We agree with the reviewer that this is an important possibility. We tried available OGT antibodies for Western blot and immunofluorescence (to retain cell specificity), but they were not functional. In 2019 we attempted to generate rabbit polyclonal antibodies against OGT based on the two peptides below, as recommended by protein chemists:

DmOGT(570-592): KPYNFLKKLPTKGRLRIGYLSSD

DmOGT(1045-1059): Cys-EKYENGELPDHISAV

We injected 4 different rabbits, which gave rise to two different polyclonals per peptide. To our disappointment, none of the found antibodies showed a specific signal in Western blot and immunofluorescence experiments. We originally mentioned OGT compartmentalization in the discussion, but we agree that this point needs more stress, so we added it to the “limitation” portion of the discussion.

4) In Figure 2A, the authors describe a high correlation in chromatin binding sites between Pcl and OGT, concluding that the overlapping OGTXPRC2.1 regions are a critical subset for sweet tasting response. However, these overlapping regions are a rather small subset of sites, with the largest subset actually belonging the "yellow" H3K4/H3K36 euchromatin subset. It is unclear from this analysis why the authors chose to pursue the blue chromatin instead. It would be important to rank regulatory regions bound by DAM:OGT alone and DAM:Pcl alone to establish the primary regions of binding for both OGT and Pcl irrespective of each other. These regions can then be compared with the known sweet tasting genes to rank the relevant binding regions. Should there be other regions relevant to sweet taste that are not overlapping between OGT and Pcl that should be reported. This will also give readers a more comprehensive understanding about the role of Sr motifs and if this is a small but significant subset of genes regulated by OGT or comprise the majority of cis-regulatory regions controlled by OGT.

The OGT:dam data show that this enzyme is found at about an equal number of genes in yellow and blue chromatin (Figure 1B-D); only genes in blue chromatin are enriched for neural functions- see new text based on the suggestion to carry out more analyses on these two types of chromatin. The overlap between Pcl and OGT only occurs in a small proportion (162) of these OGT peaks, as shown in Figure 2. As we wrote in the text, the OGT/Pcl peaks are enriched in blue chromatin (permutation test); this is somewhat expected in a way since Pcl occupies blue chromatin, as shown in our previous analyses (Vaziri et al. 2020), and also demonstrated by the lower expression of the OGT x Pcl genes compared to OGT-alone (Figure 2B). Intriguingly, in (Vaziri et al. 2020) we observed that PCl-associated genes have a lower expression than non-PCl-bound genes but also show considerable variation in expression among them. The comparison in Figure 4B with Pcl vs. OGT/Pcl shows that the PCl-only genes have lower expression.

We added the enrichment for cis-regulatory regions among OGT-bound, PCl-bound, and OGT/Pcl and OGT/PREs regulatory regions in the supplementary excel file; the breakdown for Sr is shown in Figure 4A (now 5A). Very few genes are known as “sweet taste genes” outside of the sweet taste receptors, and the occupancy and expression of these sweet taste receptor genes is unchanged by diet. However, our previous molecular characterization of the sweet sensing neurons did identify two transcription factors, Ptx1, and cad, which we show here are occupied by OGT and Pcl, as mentioned in the manuscript. We took the reviewer’s suggestion and analyzed the GO terms and accessibility for OGT occupancy among yellow and blue chromatin (Figure 1-Supplement 1). We found that only blue genes showed enrichment in GO terms, which are a subset of those found in the OGT/Pcl genes. We discuss the results of the analysis in the text.

5) The authors use PCL as a proxy for PRC2.1 activity as it is the recruiter for PRC2.1. However, why wasn't DAM::PRC2.1 performed to directly compare to OGT? This data should be provided to show the overlap of PRC2.1 to Pcl or it should be explained in the results.

We manipulated and measured Pcl binding instead of Ez because this manipulation is more specific. The PRC2 complex comes in many different “flavors,” all of which contain Ez. Each of the PRC2 variants is characterized by a different recruiter, which targets the complex to specific regions of chromatin (i.e., Pcl has a Tudor domain which is thought to target PRC2.1, the PCl-containing PRC2, to actively transcribed chromatin). Thus, by manipulating and targeting Pcl, we can isolate a specific type of PRC2.1, and as we showed in (Vaziri et al. 2020), the other PRC2 variants do not play a role in taste plasticity; in that manuscript, we also show that Pcl, Ez, Suz12, and Esc mutants phenocopy one another, and that the effects of Pcl on taste are indeed dependent on the catalytic activity of Ez. In the revised version of Figure 4, we now show that OGT expression requires Pcl and a catalytically active PRC2 to mediate its effect on taste plasticity (4D).

6) The authors findings are performed using flies overexpressing Pcl or OGT in Gr5a expressing cells for the TADA, PER experiments, and electrophysiology analysis. Because this analysis is based on an overexpression of the gene of interest, I believe it is important to repeat these experiments in flies overexpressing these genes in neurons unrelated to the sweet taste response- such as in the neighboring bitter taste neurons. This is especially a critical set of experiments to do, as the primary thesis of this study is about how each cell alters its nutrigenomic signaling in different cell types, but the analysis is primarily focused on DAM-ID datasets from overexpressed OGT in Gr5a. The study would be relevant if the authors did comparative analysis of OGT-PRC interactions in neurons that have different sensitivities or taste modalities to sugar.

The expression of Pcl and OGT for the molecular experiment only occurs for 18 hours. We do not solely use overexpression, but also RNAi, loss of function alleles, and genetic manipulations compared to overexpression. Importantly, we show that our manipulations only have an effect in combination with an environmental variable (diet, i.e., OGT RNAi, OGT mutants, and Pcl mutants).

(As in the authors’ recommendation response): This study is a cell-specific investigation of nutrigenomic mechanisms in the Gr5a+ sweet taste neurons; it was not our intention to examine mechanisms across different cell types. However, we can understand the reviewers’ comments about this after rereading the abstract and introduction. As such, we have rewritten part of the manuscript to better introduce the rationale behind the study as the integration of metabolic signaling and cellular contexts. We hope this is now an improved framing for the study rationale.

About analyzing the effects of diet on other cells, no doubt this is an interesting question. However, this also signifies embarking on a completely separate project that would take, optimistically speaking, at least one year to complete and require a budget of ~ $130,000 (see breakdown). Thus, this suggestion doesn’t seem in line with the peer review and editorial philosophy of eLife. Carrying out this new project would result in an additional 6-7 figures but would not fundamentally change the conclusion of the current work; in fact, it may even take away from the targeted integration of molecular biology and neuroscience we have tried to achieve.

Beyond this, we do not have such an unallocated budget, and so this new project would require us first to generate preliminary data on the bitter neurons to write then a grant proposal to fund it; as you can appreciate, this would take longer than a year, especially since we do not even know if the bitter gustatory neurons are affected by a high-sugar diet. Beyond this, looking at the bitter neurons would do little to prove specificity. If we found no effects of this pathway on the activity of the bitter neurons, it wouldn’t establish that the changes in the sweet taste neurons are specific. In fact, the same pathway could be acting in some of the other thousands of fly circuits that were not investigated (Black swan effect). If we did find that OGT/PRC2/Sr play a role in the bitter neurons, it would also do little to disprove specificity since their targets would likely be different because the sets of genes expressed in these two sensory neurons are different. By analogy, the protein sensor mTOR is expressed and active in every cell, where it modulates some of the same targets (i.e., S6K); however, the effects of the pathway may be different due to the distinct metabolic and genetic idiosyncrasies of cells, as well as cellular compartments. This lack of specificity doesn’t mean that mTOR is not important. Finally, we would like to note that we have tested the effects of manipulating OGT levels in other neurons (dopamine and Mushroom Body Output Neurons) without effects on behavior or neural responses (May et al. 2020; Pardo-Garcia et al. 2022); based on these, OGT doesn’t seem to affect neurons indiscriminately.

Budget ~ $129,000

Salary and fringe benefits for PD for 10 calendar months: $75,000 (2 months behavior experiments, 2 months training for molecular biology experiments and troubleshooting in new neurons, 4 months growing flies and conducting experiments, 2 months data analysis and visualization)

DAM ID: $16,0000, Pcl:dam and OGT:dam in CD and SD, with and without OSMI x 4 biological replicates per condition = 32 samples @ $500 per sample (UM Genomics core)

TRAP: $16,0000 Pcl mutant and OSMI in CD and SD x 4 biological replicates per condition + sequencing input = 32 samples @ $500 per sample (UM Genomics core)

Animals' food and maintenance: $ 5,000, $500 per person/10 months

Reagents: = $17,000, including sequencing kit (32 reactions = $6,000) x 2 = $12,000, and other reagents such as drugs and plastic

Note that this PD would have to be hired and retrained. The first author of the manuscript who carried out the molecular experiments graduated in Dec 2021 but failed to pass on the technical knowledge due to COVID restrictions at the UM: we were completely shut down until July 2020, and at 20% capacity from March 2020 to July 2021 (people couldn’t also work together to show techniques), and no new people joined the lab in 2020-2022 (most of the 2021 grad student class deferred to 2022 and no PD candidates apply).

7) The Proboscis extension response needs to be further elaborated on. The data plotted seems to be normalized but this is not explained in the paper. What is actually being measure? What is the N? If the data is normalized, then the authors should present raw data graphed in a supplemental figure at least.

The data shown are the raw data plotted as mean +/- SEM. In the proboscis extension response, what is measured is the extent of the proboscis extension when the fly labellum is stimulated with different sucrose concentrations. The extent of proboscis extension is measured as 1 = full extension, 0.5=half extension, and 0=no extension. We added this as a diagram in Figure 3A.

8) Figure 4B seems misleading in the way it is plotted. Authors claim a bias of SR genes at the TSS in the PRC2.1 and OGT overlapping regions. However, the y axes are not to the same scale. In fact, the not OGT/PRC2 regions have much higher number of genes with SR motifs at every single position plotted on 4B. Specifically the strong statements findings in the results paragraph on lines 262-283 are not sufficiently supported and the authors are encouraged to revise this or move it to discussion.

4B (Now 5B) plots the distribution of Sr binding sites along the regions up and downstream of the TSS. The reason for the difference in the Y axis is that far more genes have Sr binding sites and do not have OGT/PRC2/Pcl. What the graph clearly shows, however, is where the position of Sr is relative to the TSS, and the pattern is opposite between OGT/Pcl and non-OGT-Pcl. To address the reviewer’s comment, we have now normalized the counts relative to the genome-wide expectation (derived by multiplying the number of potential target genes by the fractional coverage of Sr motifs on the genome); a score of 1.0 indicates the hypothetical genome-wide average overlap with Sr motifs and is shown as a red dashed line. This normalized analysis shows an even stronger enrichment of Sr at the TSS of OGT/PRC2/Pcl genes.

9) Many of the experiments involved moving flies to OSMI or Trametinib diets. A caveat to this method is that this treatment will influence OGT/ERK in the fly globally. Because both OGT/ERK impact a number of critical biological processes, this makes the results difficult to interpret as impacts of taste sensing or due to the flies being generally unhealthy. It would be helpful to see fly survival on control, OSMI supplemented, and Trametinib diets to determine how detrimental these diet conditions are in general to the fly.

We have now added these experiments to Figure 4-Supplement 1A. There is no effect on survival. Also, OSMI and Trametinib affect the taste system in specific dietary contexts, not indiscriminately.

10) In general, the figure legends and methods are lacking in detail. For instance, in Figure 1F, are the GO terms for control diet comprised from all peaks listed or just the peaks unique to CD? Same question for the SD GO terms. Abbreviations are not elaborated in the legend or methods (ex: Figure 2B TPM) or lacking axis labels (ex: Figure 2D), etc. I suggest a thorough review of the methods and legend to add details necessary to interpret the results and make it possible to replicate experimental designs.

In Figure 1, “CD” means the Control diet only GO terms, “SD” means the Sugar diet only go terms, and SD/CD the differential binding go terms. We further clarified this in the legends and text and added the missing abbreviation.

Reviewer #2 (Recommendations for the authors):

1. There are too many instances of non-technical phrases that are unclear/nonspecific. For example, "…OGT moonlights on the chromatin ….", or "… OGT decorates nutrient-sensitive …". These phrases should be replaced with more precise words, unless these phrases are common in the field and I am just unaware.

We were also surprised to see these terms used in the literature. However, “moonlight” is indeed generally used to describe alternative functions of enzymes, especially metabolic enzymes. The term was generated early in the 2000s, but it has been used more in the last 5-10 years; currently, there are 1,700 manuscripts on Pubmed that use “moonlight” as we did in the manuscript. “Decorate” first originated to describe post-translational or non-enzymatic modifications to histones, but more recently, it has also been used to refer to the association of a protein with chromatin or nucleic acids; this is widely used in the epigenetics field, perhaps because some find that using “binding” or “association” may imply direct interactions with DNA or chromatin. Here are some recent examples:

Chaoyun Pan, Bo Li, M Celeste Simon. Moonlighting functions of metabolic enzymes and metabolites in cancer. Mol Cell. 2021 Sep 16;81(18):3760-3774. doi: 10.1016/j.molcel.2021.08.031.

Boukouris AE, Zervopoulos SD, Michelakis ED. Metabolic Enzymes Moonlighting in the Nucleus: Metabolic Regulation of Gene Transcription. Trends in Biochemical Sciences, 23 Jun 2016, 41(8):712-730 DOI: 10.1016/j.tibs.2016.05.013

Youjun Zhang, Arun Sampathkumar, Sandra Mae-Lin Kerber, Corné Swart, Carsten Hille, Kumar Seerangan, Alexander Graf, Lee Sweetlove & Alisdair R. Fernie. A moonlighting role for enzymes of glycolysis in the colocalization of mitochondria and chloroplasts. Nature Communications volume. 11, Article number: 4509 (2020)

From Arnould C, Rocher V, Finoux AL, Clouaire T, Li K, Zhou F, Caron P, Mangeot PE, Ricci EP, Mourad R, Haber JE, Noordermeer D, Legube G. Loop extrusion as a mechanism for formation of DNA damage repair foci. Nature. 2021 Feb;590(7847):660-665. “When a DSB forms, the PI3K-related ATM kinase rapidly triggers the establishment of megabase-sized, chromatin domains decorated with phosphorylated histone H2AX (gammaH2AX), which act as seeds for the formation of DNA-damage response foci.”

Chul-Hwan Lee, Jia-Ray Yu,1,7 Sunil Kumar, Ying Jin,3 Gary LeRoy, Natarajan Bhanu, Syuzo Kaneko, Benjamin A. Garcia, Andrew D. Hamilton, and Danny Reinberg. Allosteric activation dictates PRC2 activity independent of its recruitment to chromatin. Mol Cell. 2018 May 3; 70(3): 422–434.e6. “Mammalian heterochromatin contains large repressive chromatin domains, including H3K9me2/3-decorated constitutive heterchromatin at pericentromeric and telomeric regions.”

2. The Discussion section is overall too long and delves too much into the previous literature. It should be condensed and there should be more focus on the translational implications of the results.

We thank the reviewer for the comment; we have edited and shortened the discussion.

Reviewer #3 (Recommendations for the authors):

– Almost all quantitative data in figures lack definition of variance measures (e.g. Panel 3C and E). Are data represented as mean +/I standard deviation, s.e.m.?

We wrote this in the methods but not in each legend; we apologize for the omission and have now added this to each legend.

– Regarding setting up the problem – claiming "how nutritional information is transmuted to neural activity and behavioral changes remains elusive" is inaccurate – we know the receptors, increasingly many cells in the food intake regulatory circuit from sensory input to motor output in Drosophila.

It was not our intention to downplay previous findings; we used nutritional information to refer to metabolic signaling, but the reviewer's point is correct that the circuitry and molecular perception of sugar are well-established and characterized in flies and thus responses to nutritional information. We have now edited this sentence to make it clearer to what we wanted to refer to.

– Methods refer to a python code on Github but no github repository is specified.

We apologize for the omission; we have added the python script to the supplementary file 2.

– Please also make the code for analyzing the DaMID and CaTaDa available online.

The protocol and code we used to analyze these data were published in (Marshall and Brand 2015). We did not generate a new analysis code.

References

Mariappa, Daniel, Xiaowei Zheng, Marianne Schimpl, Olawale Raimi, Andrew T. Ferenbach,H-Arno J. Müller, and Daan M. F. van Aalten. 2015. “Dual Functionality of O-GlcNAc Transferase Is Required for Drosophila Development.” Open Biology 5 (12): 150234.

Marshall, Owen J., and Andrea H. Brand. 2015. “Damidseq_pipeline: An Automated Pipeline for Processing DamID Sequencing Datasets.” Bioinformatics 31 (20): 3371–73.

May, Christina E., Julia Rosander, Jennifer Gottfried, Evan Dennis, and Monica Dus. 2020. “Dietary Sugar Inhibits Satiation by Decreasing the Central Processing of Sweet Taste.” eLife 9 (June). https://doi.org/10.7554/eLife.54530.

Ortiz-Meoz, Rodrigo F., Jiaoyang Jiang, Michael B. Lazarus, Marina Orman, John Janetzko, Chenguang Fan, Damien Y. Duveau, Zhi-Wei Tan, Craig J. Thomas, and Suzanne Walker.

2015. “A Small Molecule That Inhibits OGT Activity in Cells.” ACS Chemical Biology 10 (6): 1392–97.

Vaziri, Anoumid, Morteza Khabiri, Brendan T. Genaw, Christina E. May, Peter L. Freddolino, and Monica Dus. 2020. “Persistent Epigenetic Reprogramming of Sweet Taste by Diet.” Science Advances 6 (46). https://doi.org/10.1126/sciadv.abc8492.

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Data Citations

    1. Sung and Vaziri 2022. A nutrient information pathway links diet to taste. NCBI Gene Expression Omnibus. GSE188757
    2. Vaziri A, Khabiri M, Genaw BT, May CE. 2020. Persistent Epigenetic Reprogramming of Sweet Taste by Diet. NCBI Gene Expression Omnibus. GSE146245 [DOI] [PMC free article] [PubMed]

    Supplementary Materials

    Supplementary file 1. Excel file with the analyses of the DAM and TRAP experiments.
    elife-83979-supp1.xlsx (3.6MB, xlsx)
    MDAR checklist
    Source code 1. Python script to run the practical equivalence test (see methods).
    elife-83979-code1.zip (4.5KB, zip)

    Data Availability Statement

    Sequencing data have been deposited in GEO under accession codes: GSE188757 and GSE146245. Analyzed omics data are included in Supplementary file 1.

    The following dataset was generated:

    Sung and Vaziri 2022. A nutrient information pathway links diet to taste. NCBI Gene Expression Omnibus. GSE188757

    The following previously published dataset was used:

    Vaziri A, Khabiri M, Genaw BT, May CE. 2020. Persistent Epigenetic Reprogramming of Sweet Taste by Diet. NCBI Gene Expression Omnibus. GSE146245


    Articles from eLife are provided here courtesy of eLife Sciences Publications, Ltd

    RESOURCES